id	sid	tid	token	lemma	pos
gs-1140	1	1	georgian	georgian	PROPN
gs-1140	1	2	scientists/	scientists/	NUM
gs-1140	1	3	.	.	PUNCT
gs-1140	2	1	4	4	NUM
gs-1140	2	2	n	n	PRON
gs-1140	2	3	3	3	NUM
gs-1140	2	4	,	,	PUNCT
gs-1140	2	5	2022	2022	NUM
gs-1140	2	6	261	261	NUM
gs-1140	2	7	georgian	georgian	PROPN
gs-1140	2	8	scientists	scientist	NOUN
gs-1140	2	9	vol	vol	NOUN
gs-1140	2	10	.	.	PROPN
gs-1140	3	1	4	4	NUM
gs-1140	3	2	issue	issue	NOUN
gs-1140	3	3	4	4	NUM
gs-1140	3	4	,	,	PUNCT
gs-1140	3	5	2022	2022	NUM
gs-1140	3	6	https://doi.org/10.52340/gs.2022.04.04.29	https://doi.org/10.52340/gs.2022.04.04.29	NOUN
gs-1140	3	7	the	the	DET
gs-1140	3	8	association	association	NOUN
gs-1140	3	9	of	of	ADP
gs-1140	3	10	atopic	atopic	NOUN
gs-1140	3	11	dermatitis	dermatitis	NOUN
gs-1140	3	12	(	(	PUNCT
gs-1140	3	13	ad	ad	NOUN
gs-1140	3	14	)	)	PUNCT
gs-1140	3	15	with	with	ADP
gs-1140	3	16	anxiety	anxiety	NOUN
gs-1140	3	17	and	and	CCONJ
gs-1140	3	18	depression	depression	NOUN
gs-1140	3	19	z.	z.	PROPN
gs-1140	3	20	telia1	telia1	PROPN
gs-1140	3	21	,	,	PUNCT
gs-1140	3	22	k.	k.	PROPN
gs-1140	3	23	machavariani2	machavariani2	PROPN
gs-1140	3	24	,	,	PUNCT
gs-1140	3	25	a.	a.	NOUN
gs-1140	3	26	telia2	telia2	NOUN
gs-1140	3	27	1	1	NUM
gs-1140	3	28	md	md	PROPN
gs-1140	3	29	phd	phd	NOUN
gs-1140	3	30	student	student	NOUN
gs-1140	3	31	of	of	ADP
gs-1140	3	32	the	the	DET
gs-1140	3	33	department	department	NOUN
gs-1140	3	34	of	of	ADP
gs-1140	3	35	allergology	allergology	NOUN
gs-1140	3	36	and	and	CCONJ
gs-1140	3	37	clinical	clinical	ADJ
gs-1140	3	38	immunology	immunology	NOUN
gs-1140	3	39	of	of	ADP
gs-1140	3	40	tbilisi	tbilisi	ADJ
gs-1140	3	41	state	state	PROPN
gs-1140	3	42	medical	medical	PROPN
gs-1140	3	43	university	university	PROPN
gs-1140	3	44	2	2	NUM
gs-1140	3	45	department	department	NOUN
gs-1140	3	46	of	of	ADP
gs-1140	3	47	allergology	allergology	NOUN
gs-1140	3	48	and	and	CCONJ
gs-1140	3	49	clinical	clinical	ADJ
gs-1140	3	50	immunology	immunology	NOUN
gs-1140	3	51	of	of	ADP
gs-1140	3	52	tbilisi	tbilisi	ADJ
gs-1140	3	53	state	state	PROPN
gs-1140	3	54	medical	medical	PROPN
gs-1140	3	55	university	university	PROPN
gs-1140	3	56	abstract	abstract	ADJ
gs-1140	3	57	atopic	atopic	NOUN
gs-1140	3	58	dermatitis	dermatitis	NOUN
gs-1140	3	59	(	(	PUNCT
gs-1140	3	60	ad	ad	NOUN
gs-1140	3	61	)	)	PUNCT
gs-1140	3	62	,	,	PUNCT
gs-1140	3	63	a	a	DET
gs-1140	3	64	common	common	ADJ
gs-1140	3	65	chronic	chronic	ADJ
gs-1140	3	66	inflammatory	inflammatory	ADJ
gs-1140	3	67	skin	skin	NOUN
gs-1140	3	68	disease	disease	NOUN
gs-1140	3	69	that	that	PRON
gs-1140	3	70	may	may	AUX
gs-1140	3	71	persist	persist	VERB
gs-1140	3	72	into	into	ADP
gs-1140	3	73	adulthood	adulthood	NOUN
gs-1140	3	74	,	,	PUNCT
gs-1140	3	75	is	be	AUX
gs-1140	3	76	associated	associate	VERB
gs-1140	3	77	with	with	ADP
gs-1140	3	78	intense	intense	ADJ
gs-1140	3	79	itching	itching	NOUN
gs-1140	3	80	and	and	CCONJ
gs-1140	3	81	a	a	DET
gs-1140	3	82	high	high	ADJ
gs-1140	3	83	incidence	incidence	NOUN
gs-1140	3	84	of	of	ADP
gs-1140	3	85	sleep	sleep	NOUN
gs-1140	3	86	disturbances	disturbance	NOUN
gs-1140	3	87	[	[	X
gs-1140	3	88	1	1	NUM
gs-1140	3	89	,	,	PUNCT
gs-1140	3	90	2	2	NUM
gs-1140	3	91	]	]	PUNCT
gs-1140	3	92	.	.	PUNCT
gs-1140	4	1	the	the	DET
gs-1140	4	2	worldwide	worldwide	ADJ
gs-1140	4	3	prevalence	prevalence	NOUN
gs-1140	4	4	of	of	ADP
gs-1140	4	5	ad	ad	NOUN
gs-1140	4	6	is	be	AUX
gs-1140	4	7	15	15	NUM
gs-1140	4	8	-	-	SYM
gs-1140	4	9	20	20	NUM
gs-1140	4	10	%	%	NOUN
gs-1140	4	11	among	among	ADP
gs-1140	4	12	children	child	NOUN
gs-1140	4	13	[	[	X
gs-1140	4	14	3	3	NUM
gs-1140	4	15	]	]	PUNCT
gs-1140	4	16	and	and	CCONJ
gs-1140	4	17	1	1	NUM
gs-1140	4	18	-	-	SYM
gs-1140	4	19	3	3	NUM
gs-1140	4	20	%	%	NOUN
gs-1140	4	21	among	among	ADP
gs-1140	4	22	adults	adult	NOUN
gs-1140	4	23	.	.	PUNCT
gs-1140	5	1	psychological	psychological	ADJ
gs-1140	5	2	distress	distress	NOUN
gs-1140	5	3	is	be	AUX
gs-1140	5	4	a	a	DET
gs-1140	5	5	common	common	ADJ
gs-1140	5	6	comorbidity	comorbidity	NOUN
gs-1140	5	7	associated	associate	VERB
gs-1140	5	8	with	with	ADP
gs-1140	5	9	atopic	atopic	NOUN
gs-1140	5	10	dermatitis	dermatitis	NOUN
gs-1140	5	11	and	and	CCONJ
gs-1140	5	12	can	can	AUX
gs-1140	5	13	negatively	negatively	ADV
gs-1140	5	14	impact	impact	VERB
gs-1140	5	15	the	the	DET
gs-1140	5	16	quality	quality	NOUN
gs-1140	5	17	of	of	ADP
gs-1140	5	18	life	life	NOUN
gs-1140	5	19	[	[	X
gs-1140	5	20	4	4	NUM
gs-1140	5	21	]	]	PUNCT
gs-1140	5	22	.	.	PUNCT
gs-1140	6	1	previous	previous	ADJ
gs-1140	6	2	large	large	ADJ
gs-1140	6	3	-	-	PUNCT
gs-1140	6	4	scale	scale	NOUN
gs-1140	6	5	population	population	NOUN
gs-1140	6	6	-	-	PUNCT
gs-1140	6	7	based	base	VERB
gs-1140	6	8	studies	study	NOUN
gs-1140	6	9	have	have	AUX
gs-1140	6	10	identified	identify	VERB
gs-1140	6	11	an	an	DET
gs-1140	6	12	association	association	NOUN
gs-1140	6	13	between	between	ADP
gs-1140	6	14	ad	ad	NOUN
gs-1140	6	15	and	and	CCONJ
gs-1140	6	16	psychiatric	psychiatric	ADJ
gs-1140	6	17	illness	illness	NOUN
gs-1140	6	18	[	[	X
gs-1140	6	19	5–8	5–8	NOUN
gs-1140	6	20	]	]	PUNCT
gs-1140	6	21	.	.	PUNCT
gs-1140	7	1	children	child	NOUN
gs-1140	7	2	with	with	ADP
gs-1140	7	3	ad	ad	NOUN
gs-1140	7	4	in	in	ADP
gs-1140	7	5	the	the	DET
gs-1140	7	6	united	united	PROPN
gs-1140	7	7	states	states	PROPN
gs-1140	7	8	had	have	VERB
gs-1140	7	9	a	a	DET
gs-1140	7	10	significantly	significantly	ADV
gs-1140	7	11	higher	high	ADJ
gs-1140	7	12	prevalence	prevalence	NOUN
gs-1140	7	13	of	of	ADP
gs-1140	7	14	attention	attention	NOUN
gs-1140	7	15	-	-	PUNCT
gs-1140	7	16	deficit	deficit	NOUN
gs-1140	7	17	/	/	SYM
gs-1140	7	18	hyperactivity	hyperactivity	NOUN
gs-1140	7	19	disorder	disorder	NOUN
gs-1140	7	20	(	(	PUNCT
gs-1140	7	21	adhd	adhd	NOUN
gs-1140	7	22	,	,	PUNCT
gs-1140	7	23	depression	depression	NOUN
gs-1140	7	24	,	,	PUNCT
gs-1140	7	25	anxiety	anxiety	NOUN
gs-1140	7	26	,	,	PUNCT
gs-1140	7	27	behavioral	behavioral	ADJ
gs-1140	7	28	disorders	disorder	NOUN
gs-1140	7	29	,	,	PUNCT
gs-1140	7	30	and	and	CCONJ
gs-1140	7	31	autism	autism	NOUN
gs-1140	7	32	)	)	PUNCT
gs-1140	7	33	than	than	ADP
gs-1140	7	34	children	child	NOUN
gs-1140	7	35	without	without	ADP
gs-1140	7	36	ad	ad	NOUN
gs-1140	7	37	[	[	X
gs-1140	7	38	5	5	NUM
gs-1140	7	39	]	]	PUNCT
gs-1140	7	40	.	.	PUNCT
gs-1140	8	1	other	other	ADJ
gs-1140	8	2	authors	author	NOUN
gs-1140	8	3	[	[	X
gs-1140	8	4	6	6	NUM
gs-1140	8	5	]	]	PUNCT
gs-1140	8	6	found	find	VERB
gs-1140	8	7	that	that	SCONJ
gs-1140	8	8	taiwanese	taiwanese	ADJ
gs-1140	8	9	patients	patient	NOUN
gs-1140	8	10	with	with	ADP
gs-1140	8	11	ad	ad	NOUN
gs-1140	8	12	had	have	VERB
gs-1140	8	13	an	an	DET
gs-1140	8	14	increased	increase	VERB
gs-1140	8	15	risk	risk	NOUN
gs-1140	8	16	of	of	ADP
gs-1140	8	17	developing	develop	VERB
gs-1140	8	18	the	the	DET
gs-1140	8	19	major	major	ADJ
gs-1140	8	20	depressive	depressive	ADJ
gs-1140	8	21	disorder	disorder	NOUN
gs-1140	8	22	(	(	PUNCT
gs-1140	8	23	mdd	mdd	PROPN
gs-1140	8	24	)	)	PUNCT
gs-1140	8	25	and	and	CCONJ
gs-1140	8	26	anxiety	anxiety	NOUN
gs-1140	8	27	disorders	disorder	NOUN
gs-1140	8	28	.	.	PUNCT
gs-1140	9	1	and	and	CCONJ
gs-1140	9	2	also	also	ADV
gs-1140	9	3	,	,	PUNCT
gs-1140	9	4	depressive	depressive	ADJ
gs-1140	9	5	symptoms	symptom	NOUN
gs-1140	9	6	were	be	AUX
gs-1140	9	7	significantly	significantly	ADV
gs-1140	9	8	higher	high	ADJ
gs-1140	9	9	in	in	ADP
gs-1140	9	10	patients	patient	NOUN
gs-1140	9	11	with	with	ADP
gs-1140	9	12	ad	ad	NOUN
gs-1140	9	13	than	than	ADP
gs-1140	9	14	in	in	ADP
gs-1140	9	15	the	the	DET
gs-1140	9	16	control	control	NOUN
gs-1140	9	17	group	group	NOUN
gs-1140	9	18	[	[	X
gs-1140	9	19	7	7	NUM
gs-1140	9	20	,	,	PUNCT
gs-1140	9	21	8	8	NUM
gs-1140	9	22	]	]	PUNCT
gs-1140	9	23	.	.	PUNCT
gs-1140	10	1	this	this	DET
gs-1140	10	2	study	study	NOUN
gs-1140	10	3	aimed	aim	VERB
gs-1140	10	4	to	to	PART
gs-1140	10	5	evaluate	evaluate	VERB
gs-1140	10	6	the	the	DET
gs-1140	10	7	association	association	NOUN
gs-1140	10	8	of	of	ADP
gs-1140	10	9	ad	ad	NOUN
gs-1140	10	10	with	with	ADP
gs-1140	10	11	anxiety	anxiety	NOUN
gs-1140	10	12	and	and	CCONJ
gs-1140	10	13	depression	depression	NOUN
gs-1140	10	14	using	use	VERB
gs-1140	10	15	a	a	DET
gs-1140	10	16	data	data	NOUN
gs-1140	10	17	mining	mining	NOUN
gs-1140	10	18	approach	approach	NOUN
gs-1140	10	19	to	to	PART
gs-1140	10	20	match	match	VERB
gs-1140	10	21	patients	patient	NOUN
gs-1140	10	22	with	with	ADP
gs-1140	10	23	ad	ad	NOUN
gs-1140	10	24	with	with	ADP
gs-1140	10	25	controls	control	NOUN
gs-1140	10	26	by	by	ADP
gs-1140	10	27	sex	sex	NOUN
gs-1140	10	28	and	and	CCONJ
gs-1140	10	29	age	age	NOUN
gs-1140	10	30	.	.	PUNCT
gs-1140	11	1	materials	material	NOUN
gs-1140	11	2	and	and	CCONJ
gs-1140	11	3	methods	method	NOUN
gs-1140	11	4	patients	patient	NOUN
gs-1140	11	5	with	with	ADP
gs-1140	11	6	atopic	atopic	NOUN
gs-1140	11	7	dermatitis	dermatitis	NOUN
gs-1140	11	8	were	be	AUX
gs-1140	11	9	interviewed	interview	VERB
gs-1140	11	10	at	at	ADP
gs-1140	11	11	the	the	DET
gs-1140	11	12	allergology	allergology	NOUN
gs-1140	11	13	and	and	CCONJ
gs-1140	11	14	clinical	clinical	ADJ
gs-1140	11	15	immunology	immunology	NOUN
gs-1140	11	16	department	department	NOUN
gs-1140	11	17	of	of	ADP
gs-1140	11	18	the	the	DET
gs-1140	11	19	tbilisi	tbilisi	ADJ
gs-1140	11	20	state	state	PROPN
gs-1140	11	21	medical	medical	PROPN
gs-1140	11	22	university	university	NOUN
gs-1140	11	23	clinics	clinic	NOUN
gs-1140	11	24	.	.	PUNCT
gs-1140	12	1	their	their	PRON
gs-1140	12	2	medical	medical	ADJ
gs-1140	12	3	records	record	NOUN
gs-1140	12	4	(	(	PUNCT
gs-1140	12	5	2018	2018	NUM
gs-1140	12	6	-	-	SYM
gs-1140	12	7	2021	2021	NUM
gs-1140	12	8	years	year	NOUN
gs-1140	12	9	)	)	PUNCT
gs-1140	12	10	were	be	AUX
gs-1140	12	11	analyzed	analyze	VERB
gs-1140	12	12	to	to	PART
gs-1140	12	13	determine	determine	VERB
gs-1140	12	14	the	the	DET
gs-1140	12	15	coexistence	coexistence	NOUN
gs-1140	12	16	of	of	ADP
gs-1140	12	17	this	this	DET
gs-1140	12	18	disease	disease	NOUN
gs-1140	12	19	with	with	ADP
gs-1140	12	20	anxiety	anxiety	NOUN
gs-1140	12	21	and	and	CCONJ
gs-1140	12	22	depression	depression	NOUN
gs-1140	12	23	.	.	PUNCT
gs-1140	13	1	the	the	DET
gs-1140	13	2	study	study	NOUN
gs-1140	13	3	was	be	AUX
gs-1140	13	4	conducted	conduct	VERB
gs-1140	13	5	according	accord	VERB
gs-1140	13	6	to	to	ADP
gs-1140	13	7	the	the	DET
gs-1140	13	8	case	case	NOUN
gs-1140	13	9	-	-	PUNCT
gs-1140	13	10	control	control	NOUN
gs-1140	13	11	protocol	protocol	NOUN
gs-1140	13	12	and	and	CCONJ
gs-1140	13	13	included	include	VERB
gs-1140	13	14	315	315	NUM
gs-1140	13	15	people	people	NOUN
gs-1140	13	16	aged	age	VERB
gs-1140	13	17	18	18	NUM
gs-1140	13	18	to	to	PART
gs-1140	13	19	69	69	NUM
gs-1140	13	20	.	.	PUNCT
gs-1140	14	1	the	the	DET
gs-1140	14	2	"	"	PUNCT
gs-1140	14	3	case	case	NOUN
gs-1140	14	4	"	"	PUNCT
gs-1140	14	5	and	and	CCONJ
gs-1140	14	6	"	"	PUNCT
gs-1140	14	7	control	control	NOUN
gs-1140	14	8	"	"	PUNCT
gs-1140	14	9	groups	group	NOUN
gs-1140	14	10	consisted	consist	VERB
gs-1140	14	11	of	of	ADP
gs-1140	14	12	154	154	NUM
gs-1140	14	13	people	people	NOUN
gs-1140	14	14	with	with	ADP
gs-1140	14	15	chronic	chronic	ADJ
gs-1140	14	16	atopic	atopic	NOUN
gs-1140	14	17	dermatitis	dermatitis	NOUN
gs-1140	14	18	and	and	CCONJ
gs-1140	14	19	161	161	NUM
gs-1140	14	20	randomly	randomly	ADV
gs-1140	14	21	selected	select	VERB
gs-1140	14	22	georgian	georgian	NOUN
gs-1140	14	23	scientists/	scientists/	NUM
gs-1140	14	24	.	.	PUNCT
gs-1140	15	1	4	4	NUM
gs-1140	15	2	n	n	PRON
gs-1140	15	3	3	3	NUM
gs-1140	15	4	,	,	PUNCT
gs-1140	15	5	2022	2022	NUM
gs-1140	15	6	262	262	NUM
gs-1140	15	7	healthy	healthy	ADJ
gs-1140	15	8	individuals	individual	NOUN
gs-1140	15	9	(	(	PUNCT
gs-1140	15	10	including	include	VERB
gs-1140	15	11	medical	medical	ADJ
gs-1140	15	12	students	student	NOUN
gs-1140	15	13	,	,	PUNCT
gs-1140	15	14	their	their	PRON
gs-1140	15	15	family	family	NOUN
gs-1140	15	16	members	member	NOUN
gs-1140	15	17	,	,	PUNCT
gs-1140	15	18	and	and	CCONJ
gs-1140	15	19	teaching	teach	VERB
gs-1140	15	20	staff	staff	NOUN
gs-1140	15	21	without	without	ADP
gs-1140	15	22	the	the	DET
gs-1140	15	23	presence	presence	NOUN
gs-1140	15	24	of	of	ADP
gs-1140	15	25	asthma	asthma	NOUN
gs-1140	15	26	,	,	PUNCT
gs-1140	15	27	rhinitis	rhinitis	ADJ
gs-1140	15	28	,	,	PUNCT
gs-1140	15	29	urticaria	urticaria	NOUN
gs-1140	15	30	,	,	PUNCT
gs-1140	15	31	seborrheic	seborrheic	ADJ
gs-1140	15	32	dermatitis	dermatitis	NOUN
gs-1140	15	33	,	,	PUNCT
gs-1140	15	34	psoriasis	psoriasis	NOUN
gs-1140	15	35	and	and	CCONJ
gs-1140	15	36	contact	contact	NOUN
gs-1140	15	37	dermatitis	dermatitis	PROPN
gs-1140	15	38	)	)	PUNCT
gs-1140	15	39	.	.	PUNCT
gs-1140	16	1	we	we	PRON
gs-1140	16	2	classified	classify	VERB
gs-1140	16	3	patients	patient	NOUN
gs-1140	16	4	by	by	ADP
gs-1140	16	5	age	age	NOUN
gs-1140	16	6	:	:	PUNCT
gs-1140	16	7	18	18	NUM
gs-1140	16	8	-	-	SYM
gs-1140	16	9	29	29	NUM
gs-1140	16	10	years	year	NOUN
gs-1140	16	11	old	old	ADJ
gs-1140	16	12	,	,	PUNCT
gs-1140	16	13	30	30	NUM
gs-1140	16	14	-	-	SYM
gs-1140	16	15	49	49	NUM
gs-1140	16	16	years	year	NOUN
gs-1140	16	17	old	old	ADJ
gs-1140	16	18	,	,	PUNCT
gs-1140	16	19	and	and	CCONJ
gs-1140	16	20	50	50	NUM
gs-1140	16	21	-	-	SYM
gs-1140	16	22	69	69	NUM
gs-1140	16	23	years	year	NOUN
gs-1140	16	24	old	old	ADJ
gs-1140	16	25	.	.	PUNCT
gs-1140	17	1	since	since	SCONJ
gs-1140	17	2	the	the	DET
gs-1140	17	3	severity	severity	NOUN
gs-1140	17	4	of	of	ADP
gs-1140	17	5	ad	ad	NOUN
gs-1140	17	6	is	be	AUX
gs-1140	17	7	difficult	difficult	ADJ
gs-1140	17	8	to	to	PART
gs-1140	17	9	classify	classify	VERB
gs-1140	17	10	,	,	PUNCT
gs-1140	17	11	we	we	PRON
gs-1140	17	12	assess	assess	VERB
gs-1140	17	13	the	the	DET
gs-1140	17	14	severity	severity	NOUN
gs-1140	17	15	of	of	ADP
gs-1140	17	16	the	the	DET
gs-1140	17	17	disease	disease	NOUN
gs-1140	17	18	based	base	VERB
gs-1140	17	19	on	on	ADP
gs-1140	17	20	the	the	DET
gs-1140	17	21	drugs	drug	NOUN
gs-1140	17	22	used	use	VERB
gs-1140	17	23	by	by	ADP
gs-1140	17	24	patients	patient	NOUN
gs-1140	17	25	:	:	PUNCT
gs-1140	17	26	mild	mild	ADJ
gs-1140	17	27	ad	ad	NOUN
gs-1140	17	28	(	(	PUNCT
gs-1140	17	29	patients	patient	NOUN
gs-1140	17	30	used	use	VERB
gs-1140	17	31	only	only	ADV
gs-1140	17	32	moisturisers	moisturiser	NOUN
gs-1140	17	33	and	and	CCONJ
gs-1140	17	34	topical	topical	ADJ
gs-1140	17	35	therapy	therapy	NOUN
gs-1140	17	36	topical	topical	ADJ
gs-1140	17	37	corticosteroids	corticosteroid	NOUN
gs-1140	17	38	(	(	PUNCT
gs-1140	17	39	tcs	tcs	NOUN
gs-1140	17	40	)	)	PUNCT
gs-1140	17	41	short	short	ADJ
gs-1140	17	42	course	course	NOUN
gs-1140	17	43	and	and	CCONJ
gs-1140	17	44	topical	topical	ADJ
gs-1140	17	45	calcineurin	calcineurin	NOUN
gs-1140	17	46	inhibitors	inhibitor	NOUN
gs-1140	17	47	(	(	PUNCT
gs-1140	17	48	tcis	tcis	NOUN
gs-1140	17	49	)	)	PUNCT
gs-1140	17	50	,	,	PUNCT
gs-1140	17	51	moderate	moderate	ADJ
gs-1140	17	52	ad	ad	NOUN
gs-1140	17	53	(	(	PUNCT
gs-1140	17	54	patients	patient	NOUN
gs-1140	17	55	who	who	PRON
gs-1140	17	56	received	receive	VERB
gs-1140	17	57	additional	additional	ADJ
gs-1140	17	58	oral	oral	ADJ
gs-1140	17	59	antihistamines	antihistamine	NOUN
gs-1140	17	60	)	)	PUNCT
gs-1140	17	61	,	,	PUNCT
gs-1140	17	62	and	and	CCONJ
gs-1140	17	63	severe	severe	ADJ
gs-1140	17	64	ad	ad	NOUN
gs-1140	17	65	(	(	PUNCT
gs-1140	17	66	patients	patient	NOUN
gs-1140	17	67	who	who	PRON
gs-1140	17	68	received	receive	VERB
gs-1140	17	69	other	other	ADJ
gs-1140	17	70	oral	oral	ADJ
gs-1140	17	71	immunosuppressants	immunosuppressant	NOUN
gs-1140	17	72	)	)	PUNCT
gs-1140	17	73	.	.	PUNCT
gs-1140	18	1	anxiety	anxiety	NOUN
gs-1140	18	2	and	and	CCONJ
gs-1140	18	3	depression	depression	NOUN
gs-1140	18	4	were	be	AUX
gs-1140	18	5	identified	identify	VERB
gs-1140	18	6	through	through	ADP
gs-1140	18	7	appropriate	appropriate	ADJ
gs-1140	18	8	questionnaires	questionnaire	NOUN
gs-1140	18	9	gad-7	gad-7	PUNCT
gs-1140	18	10	(	(	PUNCT
gs-1140	18	11	generalized	generalize	VERB
gs-1140	18	12	anxiety	anxiety	NOUN
gs-1140	18	13	disorder	disorder	NOUN
gs-1140	18	14	)	)	PUNCT
gs-1140	18	15	and	and	CCONJ
gs-1140	18	16	phq-9	phq-9	PUNCT
gs-1140	18	17	(	(	PUNCT
gs-1140	18	18	patient	patient	ADJ
gs-1140	18	19	health	health	NOUN
gs-1140	18	20	questionnaire	questionnaire	NOUN
gs-1140	18	21	)	)	PUNCT
gs-1140	18	22	by	by	ADP
gs-1140	18	23	allergists	allergist	NOUN
gs-1140	18	24	,	,	PUNCT
gs-1140	18	25	dermatologists	dermatologist	NOUN
gs-1140	18	26	,	,	PUNCT
gs-1140	18	27	and	and	CCONJ
gs-1140	18	28	general	general	ADJ
gs-1140	18	29	practitioners	practitioner	NOUN
gs-1140	18	30	.	.	PUNCT
gs-1140	19	1	statistical	statistical	ADJ
gs-1140	19	2	analysis	analysis	NOUN
gs-1140	19	3	was	be	AUX
gs-1140	19	4	performed	perform	VERB
gs-1140	19	5	using	use	VERB
gs-1140	19	6	software	software	NOUN
gs-1140	19	7	version	version	NOUN
gs-1140	19	8	25	25	NUM
gs-1140	19	9	spss	spss	ADJ
gs-1140	19	10	and	and	CCONJ
gs-1140	19	11	review	review	NOUN
gs-1140	19	12	manager	manager	NOUN
gs-1140	19	13	5.4.1	5.4.1	NUM
gs-1140	19	14	.	.	PUNCT
gs-1140	20	1	the	the	DET
gs-1140	20	2	study	study	NOUN
gs-1140	20	3	was	be	AUX
gs-1140	20	4	carried	carry	VERB
gs-1140	20	5	out	out	ADP
gs-1140	20	6	in	in	ADP
gs-1140	20	7	4	4	NUM
gs-1140	20	8	subgroups	subgroup	NOUN
gs-1140	20	9	according	accord	VERB
gs-1140	20	10	to	to	ADP
gs-1140	20	11	demographic	demographic	ADJ
gs-1140	20	12	and	and	CCONJ
gs-1140	20	13	clinical	clinical	ADJ
gs-1140	20	14	characteristics	characteristic	NOUN
gs-1140	20	15	.	.	PUNCT
gs-1140	21	1	odds	odd	NOUN
gs-1140	21	2	ratios	ratio	NOUN
gs-1140	21	3	(	(	PUNCT
gs-1140	21	4	ors	or	NOUN
gs-1140	21	5	)	)	PUNCT
gs-1140	21	6	utilised	utilise	VERB
gs-1140	21	7	a	a	DET
gs-1140	21	8	95	95	NUM
gs-1140	21	9	%	%	NOUN
gs-1140	21	10	confidence	confidence	NOUN
gs-1140	21	11	interval	interval	NOUN
gs-1140	21	12	,	,	PUNCT
gs-1140	21	13	with	with	ADP
gs-1140	21	14	a	a	DET
gs-1140	21	15	p	p	NOUN
gs-1140	21	16	-	-	PUNCT
gs-1140	21	17	value	value	NOUN
gs-1140	21	18	lower	low	ADJ
gs-1140	21	19	than	than	ADP
gs-1140	21	20	0.05	0.05	NUM
gs-1140	21	21	considered	consider	VERB
gs-1140	21	22	significant	significant	ADJ
gs-1140	21	23	.	.	PUNCT
gs-1140	22	1	results	result	VERB
gs-1140	22	2	demographic	demographic	ADJ
gs-1140	22	3	and	and	CCONJ
gs-1140	22	4	clinical	clinical	ADJ
gs-1140	22	5	parameters	parameter	NOUN
gs-1140	22	6	of	of	ADP
gs-1140	22	7	the	the	DET
gs-1140	22	8	study	study	NOUN
gs-1140	22	9	population	population	NOUN
gs-1140	22	10	are	be	AUX
gs-1140	22	11	presented	present	VERB
gs-1140	22	12	in	in	ADP
gs-1140	22	13	table	table	NOUN
gs-1140	22	14	.	.	PUNCT
gs-1140	23	1	1	1	X
gs-1140	23	2	.	.	X
gs-1140	23	3	there	there	PRON
gs-1140	23	4	were	be	VERB
gs-1140	23	5	no	no	DET
gs-1140	23	6	significant	significant	ADJ
gs-1140	23	7	differences	difference	NOUN
gs-1140	23	8	in	in	ADP
gs-1140	23	9	gender	gender	NOUN
gs-1140	23	10	;	;	PUNCT
gs-1140	23	11	the	the	DET
gs-1140	23	12	mean	mean	ADJ
gs-1140	23	13	age	age	NOUN
gs-1140	23	14	of	of	ADP
gs-1140	23	15	patients	patient	NOUN
gs-1140	23	16	with	with	ADP
gs-1140	23	17	ad	ad	NOUN
gs-1140	23	18	was	be	AUX
gs-1140	23	19	44.26	44.26	NUM
gs-1140	23	20	(	(	PUNCT
gs-1140	23	21	sd	sd	ADP
gs-1140	23	22	=	=	SYM
gs-1140	23	23	14.76	14.76	NUM
gs-1140	23	24	)	)	PUNCT
gs-1140	23	25	,	,	PUNCT
gs-1140	23	26	and	and	CCONJ
gs-1140	23	27	the	the	DET
gs-1140	23	28	control	control	NOUN
gs-1140	23	29	group	group	NOUN
gs-1140	23	30	was	be	AUX
gs-1140	23	31	46.38	46.38	NUM
gs-1140	23	32	(	(	PUNCT
gs-1140	23	33	sd	sd	ADP
gs-1140	23	34	=	=	SYM
gs-1140	23	35	15.91	15.91	NUM
gs-1140	23	36	)	)	PUNCT
gs-1140	23	37	.	.	PUNCT
gs-1140	24	1	the	the	DET
gs-1140	24	2	percentage	percentage	NOUN
gs-1140	24	3	ratio	ratio	NOUN
gs-1140	24	4	between	between	ADP
gs-1140	24	5	patients	patient	NOUN
gs-1140	24	6	with	with	ADP
gs-1140	24	7	ad	ad	NOUN
gs-1140	24	8	and	and	CCONJ
gs-1140	24	9	control	control	NOUN
gs-1140	24	10	was	be	AUX
gs-1140	24	11	45.4	45.4	NUM
gs-1140	24	12	%	%	NOUN
gs-1140	24	13	vs	vs	ADP
gs-1140	24	14	46.6	46.6	NUM
gs-1140	24	15	%	%	NOUN
gs-1140	24	16	in	in	ADP
gs-1140	24	17	men	man	NOUN
gs-1140	24	18	and	and	CCONJ
gs-1140	24	19	54.5	54.5	NUM
gs-1140	24	20	%	%	NOUN
gs-1140	24	21	vs	vs	ADP
gs-1140	24	22	53.4	53.4	NUM
gs-1140	24	23	%	%	NOUN
gs-1140	24	24	in	in	ADP
gs-1140	24	25	women	woman	NOUN
gs-1140	24	26	.	.	PUNCT
gs-1140	25	1	there	there	PRON
gs-1140	25	2	were	be	VERB
gs-1140	25	3	no	no	DET
gs-1140	25	4	significant	significant	ADJ
gs-1140	25	5	differences	difference	NOUN
gs-1140	25	6	in	in	ADP
gs-1140	25	7	the	the	DET
gs-1140	25	8	overall	overall	ADJ
gs-1140	25	9	number	number	NOUN
gs-1140	25	10	of	of	ADP
gs-1140	25	11	participants	participant	NOUN
gs-1140	25	12	in	in	ADP
gs-1140	25	13	ad	ad	NOUN
gs-1140	25	14	and	and	CCONJ
gs-1140	25	15	control	control	NOUN
gs-1140	25	16	(	(	PUNCT
gs-1140	25	17	or	or	CCONJ
gs-1140	25	18	=	=	SYM
gs-1140	25	19	1.09	1.09	NUM
gs-1140	25	20	,	,	PUNCT
gs-1140	25	21	95	95	NUM
gs-1140	25	22	%	%	NOUN
gs-1140	25	23	ci	ci	NOUN
gs-1140	25	24	0.80	0.80	NUM
gs-1140	25	25	-	-	SYM
gs-1140	25	26	1.49	1.49	NUM
gs-1140	25	27	)	)	PUNCT
gs-1140	25	28	and	and	CCONJ
gs-1140	25	29	gender	gender	NOUN
gs-1140	25	30	groups	group	NOUN
gs-1140	25	31	(	(	PUNCT
gs-1140	25	32	case	case	NOUN
gs-1140	25	33	vs	vs	ADP
gs-1140	25	34	control	control	NOUN
gs-1140	25	35	in	in	ADP
gs-1140	25	36	male	male	NOUN
gs-1140	25	37	,	,	PUNCT
gs-1140	25	38	or=1.05	or=1.05	NOUN
gs-1140	25	39	,	,	PUNCT
gs-1140	25	40	95	95	NUM
gs-1140	25	41	%	%	NOUN
gs-1140	25	42	ci	ci	NOUN
gs-1140	25	43	0.67	0.67	NUM
gs-1140	25	44	-	-	SYM
gs-1140	25	45	1.63	1.63	NUM
gs-1140	25	46	;	;	PUNCT
gs-1140	25	47	case	case	NOUN
gs-1140	25	48	vs	vs	ADP
gs-1140	25	49	control	control	NOUN
gs-1140	25	50	in	in	ADP
gs-1140	25	51	female	female	NOUN
gs-1140	25	52	,	,	PUNCT
gs-1140	25	53	or=0.96	or=0.96	PROPN
gs-1140	25	54	,	,	PUNCT
gs-1140	25	55	95	95	NUM
gs-1140	25	56	%	%	NOUN
gs-1140	25	57	ci	ci	NOUN
gs-1140	25	58	0.61	0.61	NUM
gs-1140	25	59	-	-	SYM
gs-1140	25	60	1.49	1.49	NUM
gs-1140	25	61	)	)	PUNCT
gs-1140	25	62	.	.	PUNCT
gs-1140	26	1	significant	significant	ADJ
gs-1140	26	2	differences	difference	NOUN
gs-1140	26	3	were	be	AUX
gs-1140	26	4	found	find	VERB
gs-1140	26	5	in	in	ADP
gs-1140	26	6	the	the	DET
gs-1140	26	7	prevalence	prevalence	NOUN
gs-1140	26	8	of	of	ADP
gs-1140	26	9	only	only	ADV
gs-1140	26	10	three	three	NUM
gs-1140	26	11	(	(	PUNCT
gs-1140	26	12	out	out	ADP
gs-1140	26	13	of	of	ADP
gs-1140	26	14	six	six	NUM
gs-1140	26	15	)	)	PUNCT
gs-1140	26	16	clinical	clinical	ADJ
gs-1140	26	17	variables	variable	NOUN
gs-1140	26	18	studied	study	VERB
gs-1140	26	19	(	(	PUNCT
gs-1140	26	20	asthma	asthma	NOUN
gs-1140	26	21	,	,	PUNCT
gs-1140	26	22	allergic	allergic	ADJ
gs-1140	26	23	rhinitis	rhinitis	NOUN
gs-1140	26	24	,	,	PUNCT
gs-1140	26	25	urticaria	urticaria	NOUN
gs-1140	26	26	,	,	PUNCT
gs-1140	26	27	respectively	respectively	ADV
gs-1140	26	28	:	:	PUNCT
gs-1140	26	29	or	or	CCONJ
gs-1140	26	30	=	=	SYM
gs-1140	26	31	0.25	0.25	NUM
gs-1140	26	32	,	,	PUNCT
gs-1140	26	33	95	95	NUM
gs-1140	26	34	%	%	NOUN
gs-1140	26	35	ci	ci	NOUN
gs-1140	26	36	0.070.90	0.070.90	NUM
gs-1140	26	37	;	;	PUNCT
gs-1140	26	38	or	or	CCONJ
gs-1140	26	39	=	=	SYM
gs-1140	26	40	0.18	0.18	NUM
gs-1140	26	41	,	,	PUNCT
gs-1140	26	42	95	95	NUM
gs-1140	26	43	%	%	NOUN
gs-1140	26	44	ci	ci	NOUN
gs-1140	26	45	0.04	0.04	NUM
gs-1140	26	46	-	-	SYM
gs-1140	26	47	0.84	0.84	NUM
gs-1140	26	48	;	;	PUNCT
gs-1140	26	49	or	or	CCONJ
gs-1140	26	50	=	=	SYM
gs-1140	26	51	0.30	0.30	NUM
gs-1140	26	52	,	,	PUNCT
gs-1140	26	53	95	95	NUM
gs-1140	26	54	%	%	NOUN
gs-1140	26	55	ci	ci	NOUN
gs-1140	26	56	0.10	0.10	NUM
gs-1140	26	57	-	-	SYM
gs-1140	26	58	0.96	0.96	NUM
gs-1140	26	59	)	)	PUNCT
gs-1140	26	60	,	,	PUNCT
gs-1140	26	61	but	but	CCONJ
gs-1140	26	62	not	not	PART
gs-1140	26	63	in	in	ADP
gs-1140	26	64	seborrheic	seborrheic	ADJ
gs-1140	26	65	dermatitis	dermatitis	NOUN
gs-1140	26	66	,	,	PUNCT
gs-1140	26	67	psoriasis	psoriasis	NOUN
gs-1140	26	68	,	,	PUNCT
gs-1140	26	69	and	and	CCONJ
gs-1140	26	70	contact	contact	NOUN
gs-1140	26	71	dermatitis	dermatitis	NOUN
gs-1140	26	72	.	.	PUNCT
gs-1140	27	1	table	table	NOUN
gs-1140	27	2	1	1	NUM
gs-1140	27	3	.	.	PUNCT
gs-1140	27	4	demographic	demographic	ADJ
gs-1140	27	5	and	and	CCONJ
gs-1140	27	6	clinical	clinical	ADJ
gs-1140	27	7	parameters	parameter	NOUN
gs-1140	27	8	of	of	ADP
gs-1140	27	9	the	the	DET
gs-1140	27	10	study	study	NOUN
gs-1140	27	11	population	population	NOUN
gs-1140	27	12	georgian	georgian	NOUN
gs-1140	27	13	scientists/	scientists/	NUM
gs-1140	27	14	.	.	PUNCT
gs-1140	28	1	4	4	NUM
gs-1140	28	2	n	n	DET
gs-1140	28	3	3	3	NUM
gs-1140	28	4	,	,	PUNCT
gs-1140	28	5	2022	2022	NUM
gs-1140	28	6	263	263	NUM
gs-1140	28	7	odds	odd	NOUN
gs-1140	28	8	ratios	ratio	NOUN
gs-1140	28	9	for	for	ADP
gs-1140	28	10	the	the	DET
gs-1140	28	11	association	association	NOUN
gs-1140	28	12	between	between	ADP
gs-1140	28	13	atopic	atopic	NOUN
gs-1140	28	14	dermatitis	dermatitis	NOUN
gs-1140	28	15	(	(	PUNCT
gs-1140	28	16	ad	ad	NOUN
gs-1140	28	17	)	)	PUNCT
gs-1140	28	18	,	,	PUNCT
gs-1140	28	19	anxiety	anxiety	NOUN
gs-1140	28	20	,	,	PUNCT
gs-1140	28	21	and	and	CCONJ
gs-1140	28	22	depression	depression	NOUN
gs-1140	28	23	stratified	stratify	VERB
gs-1140	28	24	by	by	ADP
gs-1140	28	25	age	age	NOUN
gs-1140	28	26	and	and	CCONJ
gs-1140	28	27	sex	sex	NOUN
gs-1140	28	28	,	,	PUNCT
gs-1140	28	29	are	be	AUX
gs-1140	28	30	demonstrated	demonstrate	VERB
gs-1140	28	31	in	in	ADP
gs-1140	28	32	table	table	NOUN
gs-1140	28	33	2	2	NUM
gs-1140	28	34	.	.	X
gs-1140	28	35	anxiety	anxiety	NOUN
gs-1140	28	36	was	be	AUX
gs-1140	28	37	nearly	nearly	ADV
gs-1140	28	38	1.5	1.5	NUM
gs-1140	28	39	times	time	NOUN
gs-1140	28	40	more	more	ADJ
gs-1140	28	41	prevalent	prevalent	ADJ
gs-1140	28	42	in	in	ADP
gs-1140	28	43	the	the	DET
gs-1140	28	44	ad	ad	NOUN
gs-1140	28	45	group	group	NOUN
gs-1140	28	46	than	than	ADP
gs-1140	28	47	in	in	ADP
gs-1140	28	48	the	the	DET
gs-1140	28	49	controls	control	NOUN
gs-1140	28	50	(	(	PUNCT
gs-1140	28	51	33.7	33.7	NUM
gs-1140	28	52	%	%	NOUN
gs-1140	28	53	vs	vs	ADP
gs-1140	28	54	21.7	21.7	NUM
gs-1140	28	55	%	%	NOUN
gs-1140	28	56	;	;	PUNCT
gs-1140	28	57	or	or	CCONJ
gs-1140	28	58	1.84	1.84	NUM
gs-1140	28	59	,	,	PUNCT
gs-1140	28	60	95	95	NUM
gs-1140	28	61	%	%	NOUN
gs-1140	28	62	ci	ci	PROPN
gs-1140	28	63	1.11–3.03	1.11–3.03	NUM
gs-1140	28	64	,	,	PUNCT
gs-1140	28	65	p	p	X
gs-1140	28	66	<	<	X
gs-1140	28	67	0.001	0.001	NUM
gs-1140	28	68	)	)	PUNCT
gs-1140	28	69	.	.	PUNCT
gs-1140	29	1	anxiety	anxiety	NOUN
gs-1140	29	2	prevalence	prevalence	NOUN
gs-1140	29	3	also	also	ADV
gs-1140	29	4	was	be	AUX
gs-1140	29	5	higher	high	ADJ
gs-1140	29	6	in	in	ADP
gs-1140	29	7	women	woman	NOUN
gs-1140	29	8	(	(	PUNCT
gs-1140	29	9	or	or	CCONJ
gs-1140	29	10	=	=	SYM
gs-1140	29	11	2.27	2.27	NUM
gs-1140	29	12	,	,	PUNCT
gs-1140	29	13	95	95	NUM
gs-1140	29	14	%	%	NOUN
gs-1140	29	15	ci	ci	PROPN
gs-1140	29	16	1.02–5.07	1.02–5.07	NUM
gs-1140	29	17	,	,	PUNCT
gs-1140	29	18	p	p	X
gs-1140	29	19	<	<	X
gs-1140	29	20	0.001	0.001	NUM
gs-1140	29	21	)	)	PUNCT
gs-1140	29	22	and	and	CCONJ
gs-1140	29	23	two	two	NUM
gs-1140	29	24	age	age	NOUN
gs-1140	29	25	groups	group	NOUN
gs-1140	29	26	:	:	PUNCT
gs-1140	29	27	30	30	NUM
gs-1140	29	28	-	-	SYM
gs-1140	29	29	49	49	NUM
gs-1140	29	30	y	y	PROPN
gs-1140	29	31	,	,	PUNCT
gs-1140	29	32	5060	5060	NUM
gs-1140	29	33	y	y	NOUN
gs-1140	29	34	(	(	PUNCT
gs-1140	29	35	respectively	respectively	ADV
gs-1140	29	36	or	or	CCONJ
gs-1140	29	37	=	=	SYM
gs-1140	29	38	3.93	3.93	NUM
gs-1140	29	39	,	,	PUNCT
gs-1140	29	40	95	95	NUM
gs-1140	29	41	%	%	NOUN
gs-1140	29	42	ci	ci	NOUN
gs-1140	29	43	1.04–14.90	1.04–14.90	NUM
gs-1140	29	44	,	,	PUNCT
gs-1140	29	45	p	p	X
gs-1140	29	46	<	<	X
gs-1140	29	47	0.001	0.001	NUM
gs-1140	29	48	;	;	PUNCT
gs-1140	29	49	or	or	CCONJ
gs-1140	29	50	=	=	SYM
gs-1140	29	51	3.44	3.44	NUM
gs-1140	29	52	,	,	PUNCT
gs-1140	29	53	95	95	NUM
gs-1140	29	54	%	%	NOUN
gs-1140	29	55	ci	ci	NOUN
gs-1140	29	56	1.04–11.39	1.04–11.39	NUM
gs-1140	29	57	,	,	PUNCT
gs-1140	29	58	p	p	X
gs-1140	29	59	<	<	X
gs-1140	29	60	0.001	0.001	NUM
gs-1140	29	61	)	)	PUNCT
gs-1140	29	62	.	.	PUNCT
gs-1140	30	1	there	there	PRON
gs-1140	30	2	was	be	VERB
gs-1140	30	3	no	no	DET
gs-1140	30	4	difference	difference	NOUN
gs-1140	30	5	between	between	ADP
gs-1140	30	6	the	the	DET
gs-1140	30	7	prevalence	prevalence	NOUN
gs-1140	30	8	of	of	ADP
gs-1140	30	9	depression	depression	NOUN
gs-1140	30	10	in	in	ADP
gs-1140	30	11	men	man	NOUN
gs-1140	30	12	and	and	CCONJ
gs-1140	30	13	women	woman	NOUN
gs-1140	30	14	.	.	PUNCT
gs-1140	31	1	(	(	PUNCT
gs-1140	31	2	31.2	31.2	NUM
gs-1140	31	3	%	%	NOUN
gs-1140	31	4	vs	vs	ADP
gs-1140	31	5	39.7	39.7	NUM
gs-1140	31	6	%	%	NOUN
gs-1140	31	7	;	;	PUNCT
gs-1140	31	8	or	or	CCONJ
gs-1140	31	9	0.69	0.69	NUM
gs-1140	31	10	,	,	PUNCT
gs-1140	31	11	95	95	NUM
gs-1140	31	12	%	%	NOUN
gs-1140	31	13	ci	ci	PROPN
gs-1140	31	14	1.11–3.03	1.11–3.03	NUM
gs-1140	31	15	,	,	PUNCT
gs-1140	31	16	p<0.001	p<0.001	PROPN
gs-1140	31	17	)	)	PUNCT
gs-1140	31	18	.	.	PUNCT
gs-1140	32	1	however	however	ADV
gs-1140	32	2	,	,	PUNCT
gs-1140	32	3	depression	depression	NOUN
gs-1140	32	4	was	be	AUX
gs-1140	32	5	more	more	ADV
gs-1140	32	6	prevalent	prevalent	ADJ
gs-1140	32	7	in	in	ADP
gs-1140	32	8	the	the	DET
gs-1140	32	9	following	follow	VERB
gs-1140	32	10	age	age	NOUN
gs-1140	32	11	groups	group	NOUN
gs-1140	32	12	(	(	PUNCT
gs-1140	32	13	30	30	NUM
gs-1140	32	14	-	-	SYM
gs-1140	32	15	49	49	NUM
gs-1140	32	16	y	y	NOUN
gs-1140	32	17	,	,	PUNCT
gs-1140	32	18	50	50	NUM
gs-1140	32	19	-	-	SYM
gs-1140	32	20	69	69	NUM
gs-1140	32	21	y	y	NOUN
gs-1140	32	22	;	;	PUNCT
gs-1140	32	23	or	or	CCONJ
gs-1140	32	24	=	=	SYM
gs-1140	32	25	2.78	2.78	NUM
gs-1140	32	26	,	,	PUNCT
gs-1140	32	27	95	95	NUM
gs-1140	32	28	%	%	NOUN
gs-1140	32	29	ci	ci	NOUN
gs-1140	32	30	1.09–7.06	1.09–7.06	NUM
gs-1140	32	31	,	,	PUNCT
gs-1140	32	32	or	or	CCONJ
gs-1140	32	33	=	=	NOUN
gs-1140	32	34	3.99	3.99	NUM
gs-1140	32	35	,	,	PUNCT
gs-1140	32	36	95	95	NUM
gs-1140	32	37	%	%	NOUN
gs-1140	32	38	ci	ci	NOUN
gs-1140	32	39	1.71–9.28	1.71–9.28	NUM
gs-1140	32	40	respectively	respectively	ADV
gs-1140	32	41	)	)	PUNCT
gs-1140	32	42	of	of	ADP
gs-1140	32	43	both	both	DET
gs-1140	32	44	sexes	sex	NOUN
gs-1140	32	45	.	.	PUNCT
gs-1140	33	1	table	table	NOUN
gs-1140	33	2	2	2	NUM
gs-1140	33	3	.	.	X
gs-1140	33	4	association	association	NOUN
gs-1140	33	5	between	between	ADP
gs-1140	33	6	atopic	atopic	NOUN
gs-1140	33	7	dermatitis	dermatitis	NOUN
gs-1140	33	8	(	(	PUNCT
gs-1140	33	9	ad	ad	NOUN
gs-1140	33	10	)	)	PUNCT
gs-1140	33	11	,	,	PUNCT
gs-1140	33	12	anxiety	anxiety	NOUN
gs-1140	33	13	and	and	CCONJ
gs-1140	33	14	depression	depression	NOUN
gs-1140	33	15	discussion	discussion	NOUN
gs-1140	33	16	previous	previous	ADJ
gs-1140	33	17	research	research	NOUN
gs-1140	33	18	on	on	ADP
gs-1140	33	19	the	the	DET
gs-1140	33	20	relationship	relationship	NOUN
gs-1140	33	21	between	between	ADP
gs-1140	33	22	anxiety	anxiety	NOUN
gs-1140	33	23	/	/	SYM
gs-1140	33	24	depression	depression	NOUN
gs-1140	33	25	and	and	CCONJ
gs-1140	33	26	atopic	atopic	NOUN
gs-1140	33	27	dermatitis	dermatitis	NOUN
gs-1140	33	28	has	have	AUX
gs-1140	33	29	been	be	AUX
gs-1140	33	30	inconsistent	inconsistent	ADJ
gs-1140	33	31	.	.	PUNCT
gs-1140	34	1	several	several	ADJ
gs-1140	34	2	studies	study	NOUN
gs-1140	34	3	have	have	AUX
gs-1140	34	4	reported	report	VERB
gs-1140	34	5	no	no	DET
gs-1140	34	6	significant	significant	ADJ
gs-1140	34	7	difference	difference	NOUN
gs-1140	34	8	in	in	ADP
gs-1140	34	9	anxiety	anxiety	NOUN
gs-1140	34	10	levels	level	NOUN
gs-1140	34	11	between	between	ADP
gs-1140	34	12	ad	ad	NOUN
gs-1140	34	13	patients	patient	NOUN
gs-1140	34	14	and	and	CCONJ
gs-1140	34	15	controls	control	VERB
gs-1140	34	16	[	[	X
gs-1140	34	17	1	1	NUM
gs-1140	34	18	,	,	PUNCT
gs-1140	34	19	2	2	NUM
gs-1140	34	20	]	]	PUNCT
gs-1140	34	21	and	and	CCONJ
gs-1140	34	22	no	no	DET
gs-1140	34	23	significant	significant	ADJ
gs-1140	34	24	correlation	correlation	NOUN
gs-1140	34	25	between	between	ADP
gs-1140	34	26	ad	ad	NOUN
gs-1140	34	27	severity	severity	NOUN
gs-1140	34	28	and	and	CCONJ
gs-1140	34	29	anxiety	anxiety	NOUN
gs-1140	34	30	[	[	X
gs-1140	34	31	10	10	NUM
gs-1140	34	32	]	]	PUNCT
gs-1140	34	33	.	.	PUNCT
gs-1140	35	1	however	however	ADV
gs-1140	35	2	,	,	PUNCT
gs-1140	35	3	other	other	ADJ
gs-1140	35	4	studies	study	NOUN
gs-1140	35	5	have	have	AUX
gs-1140	35	6	shown	show	VERB
gs-1140	35	7	that	that	SCONJ
gs-1140	35	8	ad	ad	NOUN
gs-1140	35	9	patients	patient	NOUN
gs-1140	35	10	are	be	AUX
gs-1140	35	11	more	more	ADV
gs-1140	35	12	likely	likely	ADJ
gs-1140	35	13	to	to	PART
gs-1140	35	14	experience	experience	VERB
gs-1140	35	15	anxiety	anxiety	NOUN
gs-1140	35	16	than	than	ADP
gs-1140	35	17	healthy	healthy	ADJ
gs-1140	35	18	individuals	individual	NOUN
gs-1140	35	19	[	[	X
gs-1140	35	20	5	5	NUM
gs-1140	35	21	,	,	PUNCT
gs-1140	35	22	6	6	NUM
gs-1140	35	23	]	]	PUNCT
gs-1140	35	24	.	.	PUNCT
gs-1140	36	1	a	a	DET
gs-1140	36	2	recent	recent	ADJ
gs-1140	36	3	large	large	ADJ
gs-1140	36	4	population	population	NOUN
gs-1140	36	5	-	-	PUNCT
gs-1140	36	6	based	base	VERB
gs-1140	36	7	study	study	NOUN
gs-1140	36	8	showed	show	VERB
gs-1140	36	9	that	that	SCONJ
gs-1140	36	10	moderate	moderate	ADJ
gs-1140	36	11	to	to	ADP
gs-1140	36	12	severe	severe	ADJ
gs-1140	36	13	ad	ad	NOUN
gs-1140	36	14	is	be	AUX
gs-1140	36	15	significantly	significantly	ADV
gs-1140	36	16	associated	associate	VERB
gs-1140	36	17	with	with	ADP
gs-1140	36	18	an	an	DET
gs-1140	36	19	increased	increase	VERB
gs-1140	36	20	risk	risk	NOUN
gs-1140	36	21	of	of	ADP
gs-1140	36	22	using	use	VERB
gs-1140	36	23	anxiolytics	anxiolytic	NOUN
gs-1140	36	24	and	and	CCONJ
gs-1140	36	25	antidepressants	antidepressant	NOUN
gs-1140	36	26	[	[	X
gs-1140	36	27	11	11	NUM
gs-1140	36	28	]	]	PUNCT
gs-1140	36	29	.	.	PUNCT
gs-1140	37	1	anxiety	anxiety	NOUN
gs-1140	37	2	and	and	CCONJ
gs-1140	37	3	depression	depression	NOUN
gs-1140	37	4	are	be	AUX
gs-1140	37	5	the	the	DET
gs-1140	37	6	primary	primary	ADJ
gs-1140	37	7	disorders	disorder	NOUN
gs-1140	37	8	associated	associate	VERB
gs-1140	37	9	with	with	ADP
gs-1140	37	10	chronic	chronic	ADJ
gs-1140	37	11	skin	skin	NOUN
gs-1140	37	12	diseases	disease	NOUN
gs-1140	37	13	.	.	PUNCT
gs-1140	38	1	this	this	DET
gs-1140	38	2	disease	disease	NOUN
gs-1140	38	3	can	can	AUX
gs-1140	38	4	contribute	contribute	VERB
gs-1140	38	5	significantly	significantly	ADV
gs-1140	38	6	to	to	ADP
gs-1140	38	7	psychological	psychological	ADJ
gs-1140	38	8	distress	distress	NOUN
gs-1140	38	9	and	and	CCONJ
gs-1140	38	10	is	be	AUX
gs-1140	38	11	often	often	ADV
gs-1140	38	12	associated	associate	VERB
gs-1140	38	13	with	with	ADP
gs-1140	38	14	other	other	ADJ
gs-1140	38	15	atopic	atopic	NOUN
gs-1140	38	16	conditions	condition	NOUN
gs-1140	38	17	such	such	ADJ
gs-1140	38	18	as	as	ADP
gs-1140	38	19	allergic	allergic	ADJ
gs-1140	38	20	rhinitis	rhinitis	NOUN
gs-1140	38	21	(	(	PUNCT
gs-1140	38	22	ar	ar	NOUN
gs-1140	38	23	)	)	PUNCT
gs-1140	38	24	and	and	CCONJ
gs-1140	38	25	asthma	asthma	NOUN
gs-1140	38	26	.	.	PUNCT
gs-1140	39	1	our	our	PRON
gs-1140	39	2	study	study	NOUN
gs-1140	39	3	confirmed	confirm	VERB
gs-1140	39	4	the	the	DET
gs-1140	39	5	association	association	NOUN
gs-1140	39	6	between	between	ADP
gs-1140	39	7	ad	ad	NOUN
gs-1140	39	8	and	and	CCONJ
gs-1140	39	9	some	some	DET
gs-1140	39	10	mental	mental	ADJ
gs-1140	39	11	illnesses	illness	NOUN
gs-1140	39	12	(	(	PUNCT
gs-1140	39	13	depression	depression	NOUN
gs-1140	39	14	and	and	CCONJ
gs-1140	39	15	anxiety	anxiety	NOUN
gs-1140	39	16	)	)	PUNCT
gs-1140	39	17	in	in	ADP
gs-1140	39	18	the	the	DET
gs-1140	39	19	30	30	NUM
gs-1140	39	20	-	-	SYM
gs-1140	39	21	69	69	NUM
gs-1140	39	22	age	age	NOUN
gs-1140	39	23	group	group	NOUN
gs-1140	39	24	compared	compare	VERB
gs-1140	39	25	to	to	ADP
gs-1140	39	26	healthy	healthy	ADJ
gs-1140	39	27	individuals	individual	NOUN
gs-1140	39	28	;	;	PUNCT
gs-1140	39	29	it	it	PRON
gs-1140	39	30	was	be	AUX
gs-1140	39	31	also	also	ADV
gs-1140	39	32	revealed	reveal	VERB
gs-1140	39	33	that	that	SCONJ
gs-1140	39	34	patients	patient	NOUN
gs-1140	39	35	with	with	ADP
gs-1140	39	36	atopic	atopic	NOUN
gs-1140	39	37	dermatitis	dermatitis	NOUN
gs-1140	39	38	suffer	suffer	VERB
gs-1140	39	39	more	more	ADV
gs-1140	39	40	often	often	ADV
gs-1140	39	41	from	from	ADP
gs-1140	39	42	diseases	disease	NOUN
gs-1140	39	43	such	such	ADJ
gs-1140	39	44	as	as	ADP
gs-1140	39	45	bronchial	bronchial	ADJ
gs-1140	39	46	asthma	asthma	NOUN
gs-1140	39	47	,	,	PUNCT
gs-1140	39	48	allergic	allergic	ADJ
gs-1140	39	49	rhinitis	rhinitis	NOUN
gs-1140	39	50	and	and	CCONJ
gs-1140	39	51	urticaria	urticaria	NOUN
gs-1140	39	52	.	.	PUNCT
gs-1140	40	1	many	many	ADJ
gs-1140	40	2	authors	author	NOUN
gs-1140	40	3	failed	fail	VERB
gs-1140	40	4	to	to	PART
gs-1140	40	5	confirm	confirm	VERB
gs-1140	40	6	the	the	DET
gs-1140	40	7	hypothesis	hypothesis	NOUN
gs-1140	40	8	that	that	PRON
gs-1140	40	9	the	the	DET
gs-1140	40	10	severity	severity	NOUN
gs-1140	40	11	and	and	CCONJ
gs-1140	40	12	duration	duration	NOUN
gs-1140	40	13	of	of	ADP
gs-1140	40	14	dermatitis	dermatitis	NOUN
gs-1140	40	15	affect	affect	VERB
gs-1140	40	16	depression	depression	NOUN
gs-1140	40	17	because	because	SCONJ
gs-1140	40	18	they	they	PRON
gs-1140	40	19	could	could	AUX
gs-1140	40	20	n't	not	PART
gs-1140	40	21	find	find	VERB
gs-1140	40	22	a	a	DET
gs-1140	40	23	correlation	correlation	NOUN
gs-1140	40	24	,	,	PUNCT
gs-1140	40	25	probably	probably	ADV
gs-1140	40	26	due	due	ADP
gs-1140	40	27	to	to	ADP
gs-1140	40	28	the	the	DET
gs-1140	40	29	shortage	shortage	NOUN
gs-1140	40	30	of	of	ADP
gs-1140	40	31	observed	observe	VERB
gs-1140	40	32	individuals	individual	NOUN
gs-1140	40	33	in	in	ADP
gs-1140	40	34	the	the	DET
gs-1140	40	35	respective	respective	ADJ
gs-1140	40	36	groups	group	NOUN
gs-1140	40	37	.	.	PUNCT
gs-1140	41	1	some	some	DET
gs-1140	41	2	publications	publication	NOUN
gs-1140	41	3	claim	claim	VERB
gs-1140	41	4	that	that	SCONJ
gs-1140	41	5	depressive	depressive	ADJ
gs-1140	41	6	symptoms	symptom	NOUN
gs-1140	41	7	in	in	ADP
gs-1140	41	8	georgian	georgian	PROPN
gs-1140	41	9	scientists/	scientists/	NUM
gs-1140	41	10	.	.	PUNCT
gs-1140	42	1	4	4	NUM
gs-1140	42	2	n	n	PRON
gs-1140	42	3	3	3	NUM
gs-1140	42	4	,	,	PUNCT
gs-1140	42	5	2022	2022	NUM
gs-1140	42	6	264	264	NUM
gs-1140	42	7	dermatological	dermatological	ADJ
gs-1140	42	8	patients	patient	NOUN
gs-1140	42	9	are	be	AUX
gs-1140	42	10	associated	associate	VERB
gs-1140	42	11	with	with	ADP
gs-1140	42	12	cosmetic	cosmetic	ADJ
gs-1140	42	13	malformations	malformation	NOUN
gs-1140	42	14	and	and	CCONJ
gs-1140	42	15	body	body	NOUN
gs-1140	42	16	image	image	NOUN
gs-1140	42	17	problems	problem	NOUN
gs-1140	42	18	[	[	X
gs-1140	42	19	12	12	NUM
gs-1140	42	20	,	,	PUNCT
gs-1140	42	21	13	13	NUM
gs-1140	42	22	]	]	PUNCT
gs-1140	42	23	and	and	CCONJ
gs-1140	42	24	that	that	SCONJ
gs-1140	42	25	most	most	ADJ
gs-1140	42	26	pruritic	pruritic	ADJ
gs-1140	42	27	depressive	depressive	ADJ
gs-1140	42	28	skin	skin	NOUN
gs-1140	42	29	diseases	disease	NOUN
gs-1140	42	30	include	include	VERB
gs-1140	42	31	psoriasis	psoriasis	NOUN
gs-1140	42	32	and	and	CCONJ
gs-1140	42	33	chronic	chronic	ADJ
gs-1140	42	34	idiopathic	idiopathic	ADJ
gs-1140	42	35	urticaria	urticaria	NOUN
gs-1140	42	36	[	[	X
gs-1140	42	37	14	14	NUM
gs-1140	42	38	]	]	PUNCT
gs-1140	42	39	.	.	PUNCT
gs-1140	43	1	the	the	DET
gs-1140	43	2	mechanisms	mechanism	NOUN
gs-1140	43	3	underlying	underlie	VERB
gs-1140	43	4	mental	mental	ADJ
gs-1140	43	5	illness	illness	NOUN
gs-1140	43	6	and	and	CCONJ
gs-1140	43	7	ad	ad	NOUN
gs-1140	43	8	are	be	AUX
gs-1140	43	9	unknown	unknown	ADJ
gs-1140	43	10	.	.	PUNCT
gs-1140	44	1	one	one	NUM
gs-1140	44	2	theoretical	theoretical	ADJ
gs-1140	44	3	tool	tool	NOUN
gs-1140	44	4	is	be	AUX
gs-1140	44	5	that	that	SCONJ
gs-1140	44	6	mental	mental	ADJ
gs-1140	44	7	illness	illness	NOUN
gs-1140	44	8	may	may	AUX
gs-1140	44	9	be	be	AUX
gs-1140	44	10	a	a	DET
gs-1140	44	11	common	common	ADJ
gs-1140	44	12	consequence	consequence	NOUN
gs-1140	44	13	of	of	ADP
gs-1140	44	14	many	many	ADJ
gs-1140	44	15	chronic	chronic	ADJ
gs-1140	44	16	illnesses	illness	NOUN
gs-1140	44	17	,	,	PUNCT
gs-1140	44	18	including	include	VERB
gs-1140	44	19	ad	ad	NOUN
gs-1140	44	20	.	.	PUNCT
gs-1140	45	1	blackman	blackman	PROPN
gs-1140	45	2	et	et	PROPN
gs-1140	45	3	al	al	PROPN
gs-1140	45	4	.	.	PUNCT
gs-1140	46	1	[	[	X
gs-1140	46	2	15	15	NUM
gs-1140	46	3	]	]	PUNCT
gs-1140	46	4	found	find	VERB
gs-1140	46	5	that	that	SCONJ
gs-1140	46	6	children	child	NOUN
gs-1140	46	7	with	with	ADP
gs-1140	46	8	chronic	chronic	ADJ
gs-1140	46	9	illnesses	illness	NOUN
gs-1140	46	10	are	be	AUX
gs-1140	46	11	at	at	ADP
gs-1140	46	12	increased	increase	VERB
gs-1140	46	13	risk	risk	NOUN
gs-1140	46	14	of	of	ADP
gs-1140	46	15	emotional	emotional	ADJ
gs-1140	46	16	and	and	CCONJ
gs-1140	46	17	behavioural	behavioural	ADJ
gs-1140	46	18	problems	problem	NOUN
gs-1140	46	19	.	.	PUNCT
gs-1140	47	1	the	the	DET
gs-1140	47	2	link	link	NOUN
gs-1140	47	3	between	between	ADP
gs-1140	47	4	mental	mental	ADJ
gs-1140	47	5	illness	illness	NOUN
gs-1140	47	6	and	and	CCONJ
gs-1140	47	7	ad	ad	NOUN
gs-1140	47	8	can	can	AUX
gs-1140	47	9	be	be	AUX
gs-1140	47	10	explained	explain	VERB
gs-1140	47	11	by	by	ADP
gs-1140	47	12	elevated	elevated	ADJ
gs-1140	47	13	levels	level	NOUN
gs-1140	47	14	of	of	ADP
gs-1140	47	15	proinflammatory	proinflammatory	ADJ
gs-1140	47	16	cytokines	cytokine	NOUN
gs-1140	47	17	in	in	ADP
gs-1140	47	18	ad	ad	NOUN
gs-1140	47	19	,	,	PUNCT
gs-1140	47	20	which	which	PRON
gs-1140	47	21	can	can	AUX
gs-1140	47	22	lead	lead	VERB
gs-1140	47	23	to	to	ADP
gs-1140	47	24	depression	depression	NOUN
gs-1140	47	25	,	,	PUNCT
gs-1140	47	26	anxiety	anxiety	NOUN
gs-1140	47	27	,	,	PUNCT
gs-1140	47	28	and	and	CCONJ
gs-1140	47	29	autism	autism	NOUN
gs-1140	47	30	[	[	X
gs-1140	47	31	15,16	15,16	NUM
gs-1140	47	32	]	]	PUNCT
gs-1140	47	33	.	.	PUNCT
gs-1140	48	1	schmitt	schmitt	PROPN
gs-1140	48	2	et	et	PROPN
gs-1140	48	3	al	al	PROPN
gs-1140	48	4	.	.	PUNCT
gs-1140	49	1	[	[	X
gs-1140	49	2	17	17	NUM
gs-1140	49	3	]	]	PUNCT
gs-1140	49	4	suggested	suggest	VERB
gs-1140	49	5	that	that	SCONJ
gs-1140	49	6	sustained	sustain	VERB
gs-1140	49	7	overexpression	overexpression	NOUN
gs-1140	49	8	of	of	ADP
gs-1140	49	9	inflammatory	inflammatory	ADJ
gs-1140	49	10	mediators	mediator	NOUN
gs-1140	49	11	released	release	VERB
gs-1140	49	12	during	during	ADP
gs-1140	49	13	atopic	atopic	NOUN
gs-1140	49	14	reactions	reaction	NOUN
gs-1140	49	15	may	may	AUX
gs-1140	49	16	influence	influence	VERB
gs-1140	49	17	brain	brain	NOUN
gs-1140	49	18	circuits	circuit	NOUN
gs-1140	49	19	.	.	PUNCT
gs-1140	50	1	several	several	ADJ
gs-1140	50	2	candidate	candidate	NOUN
gs-1140	50	3	genes	gene	NOUN
gs-1140	50	4	encoding	encode	VERB
gs-1140	50	5	significant	significant	ADJ
gs-1140	50	6	elements	element	NOUN
gs-1140	50	7	of	of	ADP
gs-1140	50	8	the	the	DET
gs-1140	50	9	immune	immune	ADJ
gs-1140	50	10	system	system	NOUN
gs-1140	50	11	and	and	CCONJ
gs-1140	50	12	proteins	protein	NOUN
gs-1140	50	13	involved	involve	VERB
gs-1140	50	14	in	in	ADP
gs-1140	50	15	regulating	regulate	VERB
gs-1140	50	16	th1	th1	PROPN
gs-1140	50	17	/	/	SYM
gs-1140	50	18	th2	th2	PROPN
gs-1140	50	19	cell	cell	NOUN
gs-1140	50	20	differentiation	differentiation	NOUN
gs-1140	50	21	and	and	CCONJ
gs-1140	50	22	effector	effector	NOUN
gs-1140	50	23	function	function	NOUN
gs-1140	50	24	for	for	ADP
gs-1140	50	25	atopic	atopic	NOUN
gs-1140	50	26	traits	trait	NOUN
gs-1140	50	27	have	have	AUX
gs-1140	50	28	been	be	AUX
gs-1140	50	29	identi	identi	ADJ
gs-1140	50	30	ed	ed	NOUN
gs-1140	50	31	[	[	X
gs-1140	50	32	18	18	NUM
gs-1140	50	33	]	]	PUNCT
gs-1140	50	34	.	.	PUNCT
gs-1140	51	1	in	in	ADP
gs-1140	51	2	particular	particular	ADJ
gs-1140	51	3	,	,	PUNCT
gs-1140	51	4	genetic	genetic	ADJ
gs-1140	51	5	variants	variant	NOUN
gs-1140	51	6	in	in	ADP
gs-1140	51	7	the	the	DET
gs-1140	51	8	gene	gene	NOUN
gs-1140	51	9	encoding	encoding	NOUN
gs-1140	51	10	signal	signal	NOUN
gs-1140	51	11	transducer	transducer	NOUN
gs-1140	51	12	and	and	CCONJ
gs-1140	51	13	activator	activator	NOUN
gs-1140	51	14	of	of	ADP
gs-1140	51	15	transcription	transcription	NOUN
gs-1140	51	16	6	6	NUM
gs-1140	51	17	(	(	PUNCT
gs-1140	51	18	stat6	stat6	NOUN
gs-1140	51	19	)	)	PUNCT
gs-1140	51	20	,	,	PUNCT
gs-1140	51	21	a	a	DET
gs-1140	51	22	key	key	ADJ
gs-1140	51	23	regulatory	regulatory	ADJ
gs-1140	51	24	element	element	NOUN
gs-1140	51	25	of	of	ADP
gs-1140	51	26	th2	th2	PROPN
gs-1140	51	27	immune	immune	ADJ
gs-1140	51	28	response	response	NOUN
gs-1140	51	29	,	,	PUNCT
gs-1140	51	30	have	have	AUX
gs-1140	51	31	been	be	AUX
gs-1140	51	32	associated	associate	VERB
gs-1140	51	33	with	with	ADP
gs-1140	51	34	atopy	atopy	NOUN
gs-1140	51	35	-	-	PUNCT
gs-1140	51	36	related	relate	VERB
gs-1140	51	37	traits	trait	NOUN
gs-1140	51	38	[	[	X
gs-1140	51	39	19	19	NUM
gs-1140	51	40	]	]	PUNCT
gs-1140	51	41	.	.	PUNCT
gs-1140	52	1	activator	activator	NOUN
gs-1140	52	2	of	of	ADP
gs-1140	52	3	transcription	transcription	NOUN
gs-1140	52	4	6	6	NUM
gs-1140	52	5	(	(	PUNCT
gs-1140	52	6	stat	stat	PROPN
gs-1140	52	7	6	6	NUM
gs-1140	52	8	)	)	PUNCT
gs-1140	52	9	is	be	AUX
gs-1140	52	10	also	also	ADV
gs-1140	52	11	highly	highly	ADV
gs-1140	52	12	expressed	express	VERB
gs-1140	52	13	in	in	ADP
gs-1140	52	14	the	the	DET
gs-1140	52	15	central	central	ADJ
gs-1140	52	16	nervous	nervous	ADJ
gs-1140	52	17	system	system	NOUN
gs-1140	52	18	and	and	CCONJ
gs-1140	52	19	is	be	AUX
gs-1140	52	20	suggested	suggest	VERB
gs-1140	52	21	to	to	PART
gs-1140	52	22	play	play	VERB
gs-1140	52	23	a	a	DET
gs-1140	52	24	significant	significant	ADJ
gs-1140	52	25	role	role	NOUN
gs-1140	52	26	in	in	ADP
gs-1140	52	27	attention	attention	NOUN
gs-1140	52	28	deficit	deficit	NOUN
gs-1140	52	29	hyperactivity	hyperactivity	NOUN
gs-1140	52	30	disorder	disorder	NOUN
gs-1140	52	31	(	(	PUNCT
gs-1140	52	32	adhd	adhd	NOUN
gs-1140	52	33	)	)	PUNCT
gs-1140	52	34	pathogenesis	pathogenesis	NOUN
gs-1140	53	1	[	[	X
gs-1140	53	2	19	19	NUM
gs-1140	53	3	]	]	PUNCT
gs-1140	53	4	.	.	PUNCT
gs-1140	54	1	in	in	ADP
gs-1140	54	2	addition	addition	NOUN
gs-1140	54	3	,	,	PUNCT
gs-1140	54	4	previous	previous	ADJ
gs-1140	54	5	research	research	NOUN
gs-1140	54	6	on	on	ADP
gs-1140	54	7	the	the	DET
gs-1140	54	8	association	association	NOUN
gs-1140	54	9	between	between	ADP
gs-1140	54	10	atopy	atopy	NOUN
gs-1140	54	11	and	and	CCONJ
gs-1140	54	12	behavioural	behavioural	ADJ
gs-1140	54	13	symptoms	symptom	NOUN
gs-1140	54	14	in	in	ADP
gs-1140	54	15	twins	twin	NOUN
gs-1140	54	16	has	have	AUX
gs-1140	54	17	supported	support	VERB
gs-1140	54	18	the	the	DET
gs-1140	54	19	hypothesis	hypothesis	NOUN
gs-1140	54	20	of	of	ADP
gs-1140	54	21	shared	share	VERB
gs-1140	54	22	genetic	genetic	ADJ
gs-1140	54	23	factors	factor	NOUN
gs-1140	54	24	in	in	ADP
gs-1140	54	25	uencing	uence	VERB
gs-1140	54	26	the	the	DET
gs-1140	54	27	risk	risk	NOUN
gs-1140	54	28	for	for	ADP
gs-1140	54	29	atopic	atopic	NOUN
gs-1140	54	30	and	and	CCONJ
gs-1140	54	31	behavioural	behavioural	ADJ
gs-1140	54	32	disorders	disorder	NOUN
gs-1140	54	33	[	[	X
gs-1140	54	34	18	18	NUM
gs-1140	54	35	]	]	PUNCT
gs-1140	54	36	.	.	PUNCT
gs-1140	55	1	conclusion	conclusion	NOUN
gs-1140	55	2	our	our	PRON
gs-1140	55	3	study	study	NOUN
gs-1140	55	4	has	have	AUX
gs-1140	55	5	shown	show	VERB
gs-1140	55	6	that	that	SCONJ
gs-1140	55	7	concomitant	concomitant	ADJ
gs-1140	55	8	diseases	disease	NOUN
gs-1140	55	9	(	(	PUNCT
gs-1140	55	10	bronchial	bronchial	ADJ
gs-1140	55	11	asthma	asthma	NOUN
gs-1140	55	12	,	,	PUNCT
gs-1140	55	13	allergic	allergic	ADJ
gs-1140	55	14	rhinitis	rhinitis	NOUN
gs-1140	55	15	and	and	CCONJ
gs-1140	55	16	urticarial	urticarial	ADJ
gs-1140	55	17	)	)	PUNCT
gs-1140	55	18	were	be	AUX
gs-1140	55	19	more	more	ADV
gs-1140	55	20	often	often	ADV
gs-1140	55	21	observed	observe	VERB
gs-1140	55	22	in	in	ADP
gs-1140	55	23	patients	patient	NOUN
gs-1140	55	24	with	with	ADP
gs-1140	55	25	atopic	atopic	NOUN
gs-1140	55	26	dermatitis	dermatitis	NOUN
gs-1140	55	27	;	;	PUNCT
gs-1140	55	28	depression	depression	NOUN
gs-1140	55	29	and	and	CCONJ
gs-1140	55	30	anxiety	anxiety	NOUN
gs-1140	55	31	are	be	AUX
gs-1140	55	32	also	also	ADV
gs-1140	55	33	more	more	ADV
gs-1140	55	34	common	common	ADJ
gs-1140	55	35	in	in	ADP
gs-1140	55	36	this	this	DET
gs-1140	55	37	condition	condition	NOUN
gs-1140	55	38	in	in	ADP
gs-1140	55	39	the	the	DET
gs-1140	55	40	30	30	NUM
gs-1140	55	41	-	-	SYM
gs-1140	55	42	69	69	NUM
gs-1140	55	43	age	age	NOUN
gs-1140	55	44	group	group	NOUN
gs-1140	55	45	.	.	PUNCT
gs-1140	56	1	the	the	DET
gs-1140	56	2	association	association	NOUN
gs-1140	56	3	of	of	ADP
gs-1140	56	4	depression	depression	NOUN
gs-1140	56	5	and	and	CCONJ
gs-1140	56	6	anxiety	anxiety	NOUN
gs-1140	56	7	with	with	ADP
gs-1140	56	8	chronic	chronic	ADJ
gs-1140	56	9	ad	ad	NOUN
gs-1140	56	10	is	be	AUX
gs-1140	56	11	not	not	PART
gs-1140	56	12	well	well	ADV
gs-1140	56	13	understood	understand	VERB
gs-1140	56	14	.	.	PUNCT
gs-1140	57	1	future	future	ADJ
gs-1140	57	2	studies	study	NOUN
gs-1140	57	3	recommend	recommend	VERB
gs-1140	57	4	exploring	explore	VERB
gs-1140	57	5	the	the	DET
gs-1140	57	6	inverse	inverse	NOUN
gs-1140	57	7	relationship	relationship	NOUN
gs-1140	57	8	between	between	ADP
gs-1140	57	9	atopic	atopic	NOUN
gs-1140	57	10	dermatitis	dermatitis	NOUN
gs-1140	57	11	and	and	CCONJ
gs-1140	57	12	psychiatric	psychiatric	ADJ
gs-1140	57	13	disorders	disorder	NOUN
gs-1140	57	14	(	(	PUNCT
gs-1140	57	15	depression	depression	NOUN
gs-1140	57	16	and	and	CCONJ
gs-1140	57	17	anxiety	anxiety	NOUN
gs-1140	57	18	)	)	PUNCT
gs-1140	57	19	.	.	PUNCT
gs-1140	58	1	reference	reference	NOUN
gs-1140	58	2	1	1	NUM
gs-1140	58	3	.	.	PUNCT
gs-1140	59	1	silverberg	silverberg	PROPN
gs-1140	59	2	ji	ji	PROPN
gs-1140	59	3	,	,	PUNCT
gs-1140	59	4	garg	garg	PROPN
gs-1140	59	5	nk	nk	PROPN
gs-1140	59	6	,	,	PUNCT
gs-1140	59	7	paller	paller	NOUN
gs-1140	59	8	as	as	ADP
gs-1140	59	9	,	,	PUNCT
gs-1140	59	10	fishbein	fishbein	PROPN
gs-1140	59	11	ab	ab	PROPN
gs-1140	59	12	,	,	PUNCT
gs-1140	59	13	zee	zee	PROPN
gs-1140	59	14	pc	pc	PROPN
gs-1140	59	15	.	.	PUNCT
gs-1140	60	1	according	accord	VERB
gs-1140	60	2	to	to	ADP
gs-1140	60	3	a	a	DET
gs-1140	60	4	us	us	PROPN
gs-1140	60	5	population	population	NOUN
gs-1140	60	6	-	-	PUNCT
gs-1140	60	7	based	base	VERB
gs-1140	60	8	study	study	NOUN
gs-1140	60	9	,	,	PUNCT
gs-1140	60	10	sleep	sleep	NOUN
gs-1140	60	11	disturbances	disturbance	NOUN
gs-1140	60	12	in	in	ADP
gs-1140	60	13	adults	adult	NOUN
gs-1140	60	14	with	with	ADP
gs-1140	60	15	eczema	eczema	NOUN
gs-1140	60	16	are	be	AUX
gs-1140	60	17	associated	associate	VERB
gs-1140	60	18	with	with	ADP
gs-1140	60	19	impaired	impaired	ADJ
gs-1140	60	20	overall	overall	ADJ
gs-1140	60	21	health	health	NOUN
gs-1140	60	22	.	.	PUNCT
gs-1140	61	1	j	j	PROPN
gs-1140	61	2	invest	invest	VERB
gs-1140	61	3	dermatol	dermatol	NOUN
gs-1140	61	4	.	.	PUNCT
gs-1140	62	1	2015	2015	NUM
gs-1140	62	2	;	;	PUNCT
gs-1140	62	3	135:56–66	135:56–66	X
gs-1140	62	4	.	.	PROPN
gs-1140	62	5	doi:10.1038	doi:10.1038	PROPN
gs-1140	62	6	/	/	SYM
gs-1140	63	1	jid.2014.325	jid.2014.325	PROPN
gs-1140	63	2	;	;	PUNCT
gs-1140	63	3	2	2	X
gs-1140	63	4	.	.	X
gs-1140	63	5	kim	kim	PROPN
gs-1140	63	6	jp	jp	PROPN
gs-1140	63	7	,	,	PUNCT
gs-1140	63	8	chao	chao	PROPN
gs-1140	63	9	lx	lx	PROPN
gs-1140	63	10	,	,	PUNCT
gs-1140	63	11	simpson	simpson	PROPN
gs-1140	63	12	el	el	PROPN
gs-1140	63	13	,	,	PUNCT
gs-1140	63	14	silverberg	silverberg	PROPN
gs-1140	63	15	ji	ji	PROPN
gs-1140	63	16	.	.	PROPN
gs-1140	63	17	persistence	persistence	NOUN
gs-1140	63	18	of	of	ADP
gs-1140	63	19	atopic	atopic	NOUN
gs-1140	63	20	dermatitis	dermatitis	NOUN
gs-1140	63	21	(	(	PUNCT
gs-1140	63	22	ad	ad	NOUN
gs-1140	63	23	):	):	PUNCT
gs-1140	63	24	a	a	DET
gs-1140	63	25	systematic	systematic	ADJ
gs-1140	63	26	review	review	NOUN
gs-1140	63	27	and	and	CCONJ
gs-1140	63	28	meta	meta	ADJ
gs-1140	63	29	-	-	PUNCT
gs-1140	63	30	analysis	analysis	NOUN
gs-1140	63	31	.	.	PUNCT
gs-1140	64	1	j	j	PROPN
gs-1140	64	2	am	be	AUX
gs-1140	64	3	acad	acad	ADJ
gs-1140	64	4	dermatol	dermatol	NOUN
gs-1140	64	5	.	.	PUNCT
gs-1140	65	1	2016	2016	NUM
gs-1140	65	2	;	;	PUNCT
gs-1140	66	1	75:681–7.e11	75:681–7.e11	X
gs-1140	66	2	.	.	PUNCT
gs-1140	66	3	doi:10.1016	doi:10.1016	PROPN
gs-1140	66	4	/	/	SYM
gs-1140	66	5	j.jaad.2016.05.028	j.jaad.2016.05.028	PROPN
gs-1140	66	6	;	;	PUNCT
gs-1140	66	7	3	3	X
gs-1140	66	8	.	.	X
gs-1140	66	9	asher	asher	PROPN
gs-1140	66	10	mi	mi	PROPN
gs-1140	66	11	,	,	PUNCT
gs-1140	66	12	montfort	montfort	PROPN
gs-1140	66	13	s	s	PROPN
gs-1140	66	14	,	,	PUNCT
gs-1140	66	15	bjorksten	bjorksten	ADJ
gs-1140	66	16	b	b	NOUN
gs-1140	66	17	,	,	PUNCT
gs-1140	66	18	et	et	PROPN
gs-1140	66	19	al	al	PROPN
gs-1140	66	20	.	.	PROPN
gs-1140	67	1	worldwide	worldwide	ADJ
gs-1140	67	2	time	time	NOUN
gs-1140	67	3	trends	trend	NOUN
gs-1140	67	4	in	in	ADP
gs-1140	67	5	the	the	DET
gs-1140	67	6	prevalence	prevalence	NOUN
gs-1140	67	7	of	of	ADP
gs-1140	67	8	symptoms	symptom	NOUN
gs-1140	67	9	of	of	ADP
gs-1140	67	10	asthma	asthma	NOUN
gs-1140	67	11	,	,	PUNCT
gs-1140	67	12	allergic	allergic	ADJ
gs-1140	67	13	rhinoconjunctivitis	rhinoconjunctivitis	NOUN
gs-1140	67	14	,	,	PUNCT
gs-1140	67	15	and	and	CCONJ
gs-1140	67	16	eczema	eczema	NOUN
gs-1140	67	17	in	in	ADP
gs-1140	67	18	childhood	childhood	NOUN
gs-1140	67	19	:	:	PUNCT
gs-1140	67	20	isaac	isaac	PROPN
gs-1140	67	21	phases	phase	VERB
gs-1140	67	22	one	one	NUM
gs-1140	67	23	and	and	CCONJ
gs-1140	67	24	three	three	NUM
gs-1140	67	25	repeat	repeat	PROPN
gs-1140	67	26	multicounty	multicounty	NOUN
gs-1140	67	27	cross	cross	ADJ
gs-1140	67	28	-	-	ADJ
gs-1140	67	29	sectional	sectional	ADJ
gs-1140	67	30	surveys	survey	NOUN
gs-1140	67	31	.	.	PUNCT
gs-1140	68	1	lancet	lancet	NOUN
gs-1140	68	2	.	.	PUNCT
gs-1140	69	1	2006	2006	NUM
gs-1140	69	2	;	;	PUNCT
gs-1140	69	3	368:733–743	368:733–743	NUM
gs-1140	69	4	.	.	PUNCT
gs-1140	69	5	doi:10.1016	doi:10.1016	PROPN
gs-1140	69	6	/	/	SYM
gs-1140	69	7	s01406736(06)69283	s01406736(06)69283	PROPN
gs-1140	69	8	-	-	PUNCT
gs-1140	69	9	0	0	NUM
gs-1140	69	10	;	;	PUNCT
gs-1140	69	11	georgian	georgian	PROPN
gs-1140	69	12	scientists/	scientists/	NUM
gs-1140	69	13	.	.	PUNCT
gs-1140	70	1	4	4	NUM
gs-1140	70	2	n	n	PRON
gs-1140	70	3	3	3	NUM
gs-1140	70	4	,	,	PUNCT
gs-1140	70	5	2022	2022	NUM
gs-1140	70	6	265	265	NUM
gs-1140	70	7	4	4	NUM
gs-1140	70	8	.	.	PUNCT
gs-1140	71	1	wittkowski	wittkowski	PROPN
gs-1140	71	2	a	a	X
gs-1140	71	3	,	,	PUNCT
gs-1140	71	4	richards	richards	PROPN
gs-1140	71	5	hl	hl	NOUN
gs-1140	71	6	,	,	PUNCT
gs-1140	71	7	grif	grif	PROPN
gs-1140	71	8	ths	ths	PROPN
gs-1140	71	9	ce	ce	PROPN
gs-1140	71	10	,	,	PUNCT
gs-1140	71	11	et	et	PROPN
gs-1140	71	12	al	al	PROPN
gs-1140	71	13	.	.	PUNCT
gs-1140	72	1	the	the	DET
gs-1140	72	2	impact	impact	NOUN
gs-1140	72	3	of	of	ADP
gs-1140	72	4	psychological	psychological	ADJ
gs-1140	72	5	and	and	CCONJ
gs-1140	72	6	clinical	clinical	ADJ
gs-1140	72	7	factors	factor	NOUN
gs-1140	72	8	on	on	ADP
gs-1140	72	9	quality	quality	NOUN
gs-1140	72	10	of	of	ADP
gs-1140	72	11	life	life	NOUN
gs-1140	72	12	in	in	ADP
gs-1140	72	13	individuals	individual	NOUN
gs-1140	72	14	with	with	ADP
gs-1140	72	15	atopic	atopic	NOUN
gs-1140	72	16	dermatitis	dermatitis	NOUN
gs-1140	72	17	.	.	PUNCT
gs-1140	73	1	j	j	PROPN
gs-1140	73	2	psychosom	psychosom	PROPN
gs-1140	73	3	res	re	NOUN
gs-1140	73	4	.	.	PUNCT
gs-1140	73	5	2004	2004	NUM
gs-1140	73	6	;	;	PUNCT
gs-1140	74	1	57:195–200	57:195–200	NUM
gs-1140	74	2	.	.	PUNCT
gs-1140	74	3	doi:10.1016	doi:10.1016	PROPN
gs-1140	74	4	/	/	SYM
gs-1140	74	5	j.jpsychores.2004.04.371	j.jpsychores.2004.04.371	PROPN
gs-1140	74	6	;	;	PUNCT
gs-1140	74	7	5	5	X
gs-1140	74	8	.	.	PUNCT
gs-1140	74	9	yaghmaie	yaghmaie	PROPN
gs-1140	74	10	p	p	PROPN
gs-1140	74	11	,	,	PUNCT
gs-1140	74	12	koudelka	koudelka	NOUN
gs-1140	74	13	cw	cw	PROPN
gs-1140	74	14	,	,	PUNCT
gs-1140	74	15	simpson	simpson	PROPN
gs-1140	74	16	el	el	PROPN
gs-1140	74	17	.	.	PROPN
gs-1140	74	18	mental	mental	ADJ
gs-1140	74	19	health	health	NOUN
gs-1140	74	20	comorbidity	comorbidity	NOUN
gs-1140	74	21	in	in	ADP
gs-1140	74	22	patients	patient	NOUN
gs-1140	74	23	with	with	ADP
gs-1140	74	24	atopic	atopic	NOUN
gs-1140	74	25	dermatitis	dermatitis	NOUN
gs-1140	74	26	.	.	PUNCT
gs-1140	75	1	j	j	PROPN
gs-1140	75	2	allergy	allergy	PROPN
gs-1140	75	3	clin	clin	PROPN
gs-1140	75	4	immunol	immunol	PROPN
gs-1140	75	5	.	.	PUNCT
gs-1140	76	1	2013	2013	NUM
gs-1140	76	2	;	;	PUNCT
gs-1140	76	3	131:428–433	131:428–433	NUM
gs-1140	76	4	.	.	PUNCT
gs-1140	77	1	doi:10.1016	doi:10.1016	PROPN
gs-1140	77	2	/	/	SYM
gs-1140	77	3	j.jaci.2012.10.041	j.jaci.2012.10.041	PROPN
gs-1140	77	4	;	;	PUNCT
gs-1140	77	5	6	6	NUM
gs-1140	77	6	.	.	X
gs-1140	77	7	cheng	cheng	PROPN
gs-1140	77	8	cm	cm	PROPN
gs-1140	77	9	,	,	PUNCT
gs-1140	77	10	hsu	hsu	PROPN
gs-1140	77	11	jw	jw	PROPN
gs-1140	77	12	,	,	PUNCT
gs-1140	77	13	huang	huang	PROPN
gs-1140	77	14	kl	kl	PROPN
gs-1140	77	15	,	,	PUNCT
gs-1140	77	16	et	et	PROPN
gs-1140	77	17	al	al	PROPN
gs-1140	77	18	.	.	PROPN
gs-1140	77	19	risk	risk	NOUN
gs-1140	77	20	of	of	ADP
gs-1140	77	21	developing	develop	VERB
gs-1140	77	22	t	t	NOUN
gs-1140	77	23	h	h	NOUN
gs-1140	78	1	e	e	ADP
gs-1140	78	2	major	major	ADJ
gs-1140	78	3	depressive	depressive	ADJ
gs-1140	78	4	disorder	disorder	NOUN
gs-1140	78	5	and	and	CCONJ
gs-1140	78	6	anxiety	anxiety	NOUN
gs-1140	78	7	disorders	disorder	NOUN
gs-1140	78	8	among	among	ADP
gs-1140	78	9	adolescents	adolescent	NOUN
gs-1140	78	10	and	and	CCONJ
gs-1140	78	11	adults	adult	NOUN
gs-1140	78	12	with	with	ADP
gs-1140	78	13	atopic	atopic	NOUN
gs-1140	78	14	dermatitis	dermatitis	NOUN
gs-1140	78	15	:	:	PUNCT
gs-1140	78	16	a	a	DET
gs-1140	78	17	nationwide	nationwide	ADJ
gs-1140	78	18	longitudinal	longitudinal	ADJ
gs-1140	78	19	study	study	NOUN
gs-1140	78	20	.	.	PUNCT
gs-1140	79	1	j	j	PROPN
gs-1140	79	2	affect	affect	VERB
gs-1140	79	3	disord	disord	NOUN
gs-1140	79	4	.	.	PUNCT
gs-1140	80	1	2015	2015	NUM
gs-1140	80	2	;	;	PUNCT
gs-1140	80	3	178:60–65	178:60–65	NUM
gs-1140	80	4	.	.	PUNCT
gs-1140	80	5	doi:10.1016	doi:10.1016	PROPN
gs-1140	80	6	/	/	SYM
gs-1140	80	7	j.jad.2015.02.025	j.jad.2015.02.025	PROPN
gs-1140	80	8	;	;	PUNCT
gs-1140	80	9	7	7	X
gs-1140	80	10	.	.	X
gs-1140	81	1	kim	kim	PROPN
gs-1140	81	2	s	s	PROPN
gs-1140	81	3	,	,	PUNCT
gs-1140	81	4	lee	lee	PROPN
gs-1140	81	5	jy	jy	PROPN
gs-1140	81	6	,	,	PUNCT
gs-1140	81	7	oh	oh	INTJ
gs-1140	81	8	jy	jy	PROPN
gs-1140	81	9	,	,	PUNCT
gs-1140	81	10	chekal	chekal	PROPN
gs-1140	81	11	l	l	PROPN
gs-1140	81	12	,	,	PUNCT
gs-1140	81	13	lee	lee	PROPN
gs-1140	81	14	dc	dc	PROPN
gs-1140	81	15	.	.	PUNCT
gs-1140	82	1	the	the	DET
gs-1140	82	2	association	association	NOUN
gs-1140	82	3	between	between	ADP
gs-1140	82	4	atopic	atopic	NOUN
gs-1140	82	5	dermatitis	dermatitis	NOUN
gs-1140	82	6	and	and	CCONJ
gs-1140	82	7	depressive	depressive	ADJ
gs-1140	82	8	symptoms	symptom	NOUN
gs-1140	82	9	in	in	ADP
gs-1140	82	10	korean	korean	ADJ
gs-1140	82	11	adults	adult	NOUN
gs-1140	82	12	:	:	PUNCT
gs-1140	82	13	the	the	DET
gs-1140	82	14	fth	fth	PROPN
gs-1140	82	15	korea	korea	PROPN
gs-1140	82	16	national	national	PROPN
gs-1140	82	17	health	health	PROPN
gs-1140	82	18	and	and	CCONJ
gs-1140	82	19	nutrition	nutrition	NOUN
gs-1140	82	20	examination	examination	NOUN
gs-1140	82	21	survey	survey	NOUN
gs-1140	82	22	,	,	PUNCT
gs-1140	82	23	2007–2012	2007–2012	NUM
gs-1140	82	24	.	.	PUNCT
gs-1140	83	1	korean	korean	PROPN
gs-1140	83	2	j	j	PROPN
gs-1140	83	3	fam	fam	PROPN
gs-1140	83	4	med	me	VERB
gs-1140	83	5	.	.	PUNCT
gs-1140	83	6	2015	2015	NUM
gs-1140	83	7	;	;	PUNCT
gs-1140	84	1	36:261–265	36:261–265	NUM
gs-1140	84	2	.	.	PUNCT
gs-1140	84	3	doi:10.4082	doi:10.4082	PROPN
gs-1140	84	4	/	/	SYM
gs-1140	84	5	kjfm.2015.36.6.261	kjfm.2015.36.6.261	PROPN
gs-1140	84	6	;	;	PUNCT
gs-1140	84	7	8	8	NUM
gs-1140	84	8	.	.	X
gs-1140	84	9	lee	lee	PROPN
gs-1140	84	10	s	s	PROPN
gs-1140	84	11	,	,	PUNCT
gs-1140	84	12	shin	shin	PROPN
gs-1140	84	13	a.	a.	PROPN
gs-1140	84	14	association	association	PROPN
gs-1140	84	15	of	of	ADP
gs-1140	84	16	atopic	atopic	NOUN
gs-1140	84	17	dermatitis	dermatitis	NOUN
gs-1140	84	18	with	with	ADP
gs-1140	84	19	depressive	depressive	ADJ
gs-1140	84	20	symptoms	symptom	NOUN
gs-1140	84	21	and	and	CCONJ
gs-1140	84	22	suicidal	suicidal	ADJ
gs-1140	84	23	behaviours	behaviour	NOUN
gs-1140	84	24	among	among	ADP
gs-1140	84	25	adolescents	adolescent	NOUN
gs-1140	84	26	in	in	ADP
gs-1140	84	27	korea	korea	PROPN
gs-1140	84	28	:	:	PUNCT
gs-1140	84	29	the	the	DET
gs-1140	84	30	2013	2013	NUM
gs-1140	84	31	korean	korean	ADJ
gs-1140	84	32	youth	youth	NOUN
gs-1140	84	33	risk	risk	NOUN
gs-1140	84	34	behaviour	behaviour	NOUN
gs-1140	84	35	survey	survey	NOUN
gs-1140	84	36	.	.	PUNCT
gs-1140	85	1	bmc	bmc	PROPN
gs-1140	85	2	psychiatry	psychiatry	NOUN
gs-1140	85	3	.	.	PUNCT
gs-1140	86	1	2017	2017	NUM
gs-1140	86	2	;	;	PUNCT
gs-1140	87	1	17:3	17:3	NUM
gs-1140	87	2	.	.	NOUN
gs-1140	87	3	doi:10.1186	doi:10.1186	PROPN
gs-1140	87	4	/	/	SYM
gs-1140	87	5	s12888	s12888	VERB
gs-1140	87	6	-	-	ADJ
gs-1140	87	7	017	017	NUM
gs-1140	87	8	-	-	PUNCT
gs-1140	87	9	1489	1489	NUM
gs-1140	87	10	-	-	SYM
gs-1140	87	11	6	6	NUM
gs-1140	87	12	;	;	PUNCT
gs-1140	87	13	9	9	NUM
gs-1140	87	14	.	.	X
gs-1140	87	15	gupta	gupta	PROPN
gs-1140	87	16	ma	ma	PROPN
gs-1140	87	17	,	,	PUNCT
gs-1140	87	18	gupta	gupta	PROPN
gs-1140	87	19	ak	ak	PROPN
gs-1140	87	20	.	.	PUNCT
gs-1140	88	1	the	the	DET
gs-1140	88	2	use	use	NOUN
gs-1140	88	3	of	of	ADP
gs-1140	88	4	antidepressant	antidepressant	ADJ
gs-1140	88	5	drugs	drug	NOUN
gs-1140	88	6	in	in	ADP
gs-1140	88	7	dermatology	dermatology	NOUN
gs-1140	88	8	.	.	PUNCT
gs-1140	89	1	j	j	PROPN
gs-1140	89	2	eur	eur	PROPN
gs-1140	89	3	acad	acad	PROPN
gs-1140	89	4	dermatol	dermatol	NOUN
gs-1140	89	5	venereol	venereol	NOUN
gs-1140	89	6	.	.	PUNCT
gs-1140	90	1	2001	2001	NUM
gs-1140	90	2	;	;	PUNCT
gs-1140	91	1	15:512–518	15:512–518	NUM
gs-1140	91	2	.	.	PUNCT
gs-1140	91	3	doi:10.1046	doi:10.1046	ADJ
gs-1140	91	4	/	/	SYM
gs-1140	91	5	j.1468	j.1468	NOUN
gs-1140	91	6	-	-	PUNCT
gs-1140	91	7	3083.2001.00278.x	3083.2001.00278.x	NUM
gs-1140	91	8	;	;	PUNCT
gs-1140	91	9	10	10	NUM
gs-1140	91	10	.	.	PUNCT
gs-1140	92	1	linnet	linnet	PROPN
gs-1140	92	2	j	j	PROPN
gs-1140	92	3	,	,	PUNCT
gs-1140	92	4	jemec	jemec	VERB
gs-1140	92	5	gb	gb	PRON
gs-1140	92	6	.	.	PUNCT
gs-1140	93	1	an	an	DET
gs-1140	93	2	assessment	assessment	NOUN
gs-1140	93	3	of	of	ADP
gs-1140	93	4	anxiety	anxiety	NOUN
gs-1140	93	5	and	and	CCONJ
gs-1140	93	6	dermatology	dermatology	NOUN
gs-1140	93	7	life	life	NOUN
gs-1140	93	8	quality	quality	NOUN
gs-1140	93	9	in	in	ADP
gs-1140	93	10	patients	patient	NOUN
gs-1140	93	11	with	with	ADP
gs-1140	93	12	atopic	atopic	NOUN
gs-1140	93	13	dermatitis	dermatitis	NOUN
gs-1140	93	14	.	.	PUNCT
gs-1140	94	1	br	br	PROPN
gs-1140	94	2	j	j	PROPN
gs-1140	94	3	dermatol	dermatol	NOUN
gs-1140	94	4	.	.	PUNCT
gs-1140	95	1	1999	1999	NUM
gs-1140	95	2	;	;	PUNCT
gs-1140	95	3	140:268–272	140:268–272	NUM
gs-1140	95	4	.	.	PUNCT
gs-1140	96	1	doi:10.1046	doi:10.1046	ADJ
gs-1140	96	2	/	/	SYM
gs-1140	96	3	j.1365	j.1365	NOUN
gs-1140	96	4	-	-	PUNCT
gs-1140	96	5	2133.1999.02661.x	2133.1999.02661.x	NUM
gs-1140	96	6	;	;	PUNCT
gs-1140	96	7	11	11	NUM
gs-1140	96	8	.	.	PUNCT
gs-1140	97	1	thyssen	thyssen	PROPN
gs-1140	97	2	jp	jp	PROPN
gs-1140	97	3	,	,	PUNCT
gs-1140	97	4	hamann	hamann	PROPN
gs-1140	97	5	cr	cr	PROPN
gs-1140	97	6	,	,	PUNCT
gs-1140	97	7	linneberg	linneberg	PROPN
gs-1140	97	8	a	a	PRON
gs-1140	97	9	,	,	PUNCT
gs-1140	97	10	et	et	PROPN
gs-1140	97	11	al	al	PROPN
gs-1140	97	12	.	.	PUNCT
gs-1140	97	13	atopic	atopic	PROPN
gs-1140	97	14	dermatitis	dermatitis	NOUN
gs-1140	97	15	is	be	AUX
gs-1140	97	16	associated	associate	VERB
gs-1140	97	17	with	with	ADP
gs-1140	97	18	anxiety	anxiety	NOUN
gs-1140	97	19	,	,	PUNCT
gs-1140	97	20	depression	depression	NOUN
gs-1140	97	21	,	,	PUNCT
gs-1140	97	22	and	and	CCONJ
gs-1140	97	23	suicidal	suicidal	ADJ
gs-1140	97	24	ideation	ideation	NOUN
gs-1140	97	25	,	,	PUNCT
gs-1140	97	26	but	but	CCONJ
gs-1140	97	27	not	not	PART
gs-1140	97	28	with	with	ADP
gs-1140	97	29	hospitalisation	hospitalisation	NOUN
gs-1140	97	30	or	or	CCONJ
gs-1140	97	31	suicide	suicide	NOUN
gs-1140	97	32	.	.	PUNCT
gs-1140	98	1	allergy	allergy	NOUN
gs-1140	98	2	.	.	PUNCT
gs-1140	99	1	2017	2017	NUM
gs-1140	99	2	.	.	PUNCT
gs-1140	100	1	doi:10.1111/	doi:10.1111/	PROPN
gs-1140	100	2	all.13231	all.13231	NUM
gs-1140	100	3	;	;	PUNCT
gs-1140	100	4	12	12	NUM
gs-1140	100	5	.	.	PUNCT
gs-1140	101	1	gupta	gupta	PROPN
gs-1140	101	2	ma	ma	PROPN
gs-1140	101	3	,	,	PUNCT
gs-1140	101	4	gupta	gupta	PROPN
gs-1140	101	5	ak	ak	PROPN
gs-1140	101	6	.	.	PROPN
gs-1140	101	7	depression	depression	NOUN
gs-1140	101	8	and	and	CCONJ
gs-1140	101	9	suicidal	suicidal	ADJ
gs-1140	101	10	ideation	ideation	NOUN
gs-1140	101	11	in	in	ADP
gs-1140	101	12	dermatology	dermatology	NOUN
gs-1140	101	13	patients	patient	NOUN
gs-1140	101	14	with	with	ADP
gs-1140	101	15	acne	acne	NOUN
gs-1140	101	16	,	,	PUNCT
gs-1140	101	17	alopecia	alopecia	NOUN
gs-1140	101	18	areata	areata	NOUN
gs-1140	101	19	,	,	PUNCT
gs-1140	101	20	atopic	atopic	NOUN
gs-1140	101	21	dermatitis	dermatitis	NOUN
gs-1140	101	22	and	and	CCONJ
gs-1140	101	23	psoriasis	psoriasis	NOUN
gs-1140	101	24	.	.	PUNCT
gs-1140	102	1	br	br	PROPN
gs-1140	102	2	j	j	PROPN
gs-1140	102	3	dermatol	dermatol	NOUN
gs-1140	102	4	.	.	PUNCT
gs-1140	103	1	1998	1998	NUM
gs-1140	103	2	;	;	PUNCT
gs-1140	103	3	139:846–850	139:846–850	NUM
gs-1140	103	4	;	;	PUNCT
gs-1140	103	5	13	13	NUM
gs-1140	103	6	.	.	PUNCT
gs-1140	104	1	klocklokk	klocklokk	PROPN
gs-1140	104	2	m	m	PROPN
gs-1140	104	3	,	,	PUNCT
gs-1140	104	4	gotestam	gotestam	PROPN
gs-1140	104	5	kg	kg	PROPN
gs-1140	104	6	,	,	PUNCT
gs-1140	104	7	mykletun	mykletun	PROPN
gs-1140	104	8	a.	a.	NOUN
gs-1140	104	9	factors	factor	NOUN
gs-1140	104	10	accounting	account	VERB
gs-1140	104	11	for	for	ADP
gs-1140	104	12	the	the	DET
gs-1140	104	13	association	association	NOUN
gs-1140	104	14	between	between	ADP
gs-1140	104	15	anxiety	anxiety	NOUN
gs-1140	104	16	and	and	CCONJ
gs-1140	104	17	depression	depression	NOUN
gs-1140	104	18	,	,	PUNCT
gs-1140	104	19	and	and	CCONJ
gs-1140	104	20	eczema	eczema	PROPN
gs-1140	104	21	:	:	PUNCT
gs-1140	104	22	the	the	DET
gs-1140	104	23	hordaland	hordaland	NOUN
gs-1140	104	24	health	health	NOUN
gs-1140	104	25	study	study	NOUN
gs-1140	104	26	(	(	PUNCT
gs-1140	104	27	husk	husk	NOUN
gs-1140	104	28	)	)	PUNCT
gs-1140	104	29	.	.	PUNCT
gs-1140	105	1	bmc	bmc	PROPN
gs-1140	105	2	dermatol	dermatol	NOUN
gs-1140	105	3	.	.	PUNCT
gs-1140	106	1	2010	2010	NUM
gs-1140	106	2	;	;	PUNCT
gs-1140	106	3	10:3	10:3	NUM
gs-1140	106	4	.	.	PUNCT
gs-1140	106	5	doi:10.1186/1471	doi:10.1186/1471	NOUN
gs-1140	106	6	-	-	PUNCT
gs-1140	106	7	5945	5945	NUM
gs-1140	106	8	-	-	SYM
gs-1140	106	9	10	10	NUM
gs-1140	106	10	-	-	SYM
gs-1140	106	11	3	3	NUM
gs-1140	106	12	;	;	PUNCT
gs-1140	106	13	14	14	NUM
gs-1140	106	14	.	.	PUNCT
gs-1140	107	1	holloway	holloway	PROPN
gs-1140	107	2	jw	jw	PROPN
gs-1140	107	3	,	,	PUNCT
gs-1140	107	4	holgate	holgate	PROPN
gs-1140	107	5	st	st	PROPN
gs-1140	107	6	.	.	PROPN
gs-1140	107	7	genetics	genetic	NOUN
gs-1140	107	8	of	of	ADP
gs-1140	107	9	allergic	allergic	ADJ
gs-1140	107	10	disease	disease	NOUN
gs-1140	107	11	.	.	PUNCT
gs-1140	108	1	j	j	PROPN
gs-1140	108	2	allergy	allergy	PROPN
gs-1140	108	3	clin	clin	PROPN
gs-1140	108	4	immunol	immunol	PROPN
gs-1140	108	5	.	.	PUNCT
gs-1140	109	1	2010	2010	NUM
gs-1140	109	2	;	;	PUNCT
gs-1140	109	3	125	125	NUM
gs-1140	109	4	:	:	PUNCT
gs-1140	109	5	s81	s81	ADJ
gs-1140	109	6	–	–	PUNCT
gs-1140	109	7	s94	s94	ADJ
gs-1140	109	8	.	.	PUNCT
gs-1140	110	1	doi:10.1016	doi:10.1016	PROPN
gs-1140	110	2	/	/	SYM
gs-1140	110	3	j.jaci.2009.10.071	j.jaci.2009.10.071	PROPN
gs-1140	110	4	;	;	PUNCT
gs-1140	110	5	15	15	NUM
gs-1140	110	6	.	.	PUNCT
gs-1140	111	1	lau	lau	PROPN
gs-1140	111	2	m	m	PROPN
gs-1140	111	3	,	,	PUNCT
gs-1140	111	4	tsantikos	tsantikos	ADJ
gs-1140	111	5	e	e	NOUN
gs-1140	111	6	,	,	PUNCT
gs-1140	111	7	maxwell	maxwell	PROPN
gs-1140	111	8	mj	mj	PROPN
gs-1140	111	9	,	,	PUNCT
gs-1140	111	10	tarlinton	tarlinton	PROPN
gs-1140	111	11	dm	dm	PROPN
gs-1140	111	12	,	,	PUNCT
gs-1140	111	13	anderson	anderson	PROPN
gs-1140	111	14	gp	gp	PROPN
gs-1140	111	15	,	,	PUNCT
gs-1140	111	16	hibbs	hibbs	PROPN
gs-1140	111	17	ml	ml	PROPN
gs-1140	111	18	.	.	PUNCT
gs-1140	112	1	loss	loss	NOUN
gs-1140	112	2	of	of	ADP
gs-1140	112	3	stat6	stat6	NOUN
gs-1140	112	4	promotes	promote	VERB
gs-1140	112	5	autoimmune	autoimmune	ADJ
gs-1140	112	6	disease	disease	NOUN
gs-1140	112	7	and	and	CCONJ
gs-1140	112	8	atopy	atopy	NOUN
gs-1140	112	9	on	on	ADP
gs-1140	112	10	a	a	DET
gs-1140	112	11	susceptible	susceptible	ADJ
gs-1140	112	12	genetic	genetic	ADJ
gs-1140	112	13	background	background	NOUN
gs-1140	112	14	.	.	PUNCT
gs-1140	113	1	j	j	PROPN
gs-1140	113	2	autoimmun	autoimmun	PROPN
gs-1140	113	3	.	.	PUNCT
gs-1140	114	1	2012	2012	NUM
gs-1140	114	2	;	;	PUNCT
gs-1140	114	3	39:388–397	39:388–397	NUM
gs-1140	114	4	.	.	PUNCT
gs-1140	114	5	doi:10.1016	doi:10.1016	PROPN
gs-1140	114	6	/	/	SYM
gs-1140	114	7	j.jaut.2012.06.003	j.jaut.2012.06.003	PROPN
gs-1140	114	8	16	16	NUM
gs-1140	114	9	.	.	PUNCT
gs-1140	115	1	lau	lau	PROPN
gs-1140	115	2	m	m	PROPN
gs-1140	115	3	,	,	PUNCT
gs-1140	115	4	tsantikos	tsantikos	ADJ
gs-1140	115	5	e	e	NOUN
gs-1140	115	6	,	,	PUNCT
gs-1140	115	7	maxwell	maxwell	PROPN
gs-1140	115	8	mj	mj	PROPN
gs-1140	115	9	,	,	PUNCT
gs-1140	115	10	tarlinton	tarlinton	PROPN
gs-1140	115	11	dm	dm	PROPN
gs-1140	115	12	,	,	PUNCT
gs-1140	115	13	anderson	anderson	PROPN
gs-1140	115	14	gp	gp	PROPN
gs-1140	115	15	,	,	PUNCT
gs-1140	115	16	hibbs	hibbs	PROPN
gs-1140	115	17	ml	ml	PROPN
gs-1140	115	18	.	.	PUNCT
gs-1140	116	1	loss	loss	NOUN
gs-1140	116	2	of	of	ADP
gs-1140	116	3	stat6	stat6	NOUN
gs-1140	116	4	promotes	promote	VERB
gs-1140	116	5	autoimmune	autoimmune	ADJ
gs-1140	116	6	disease	disease	NOUN
gs-1140	116	7	and	and	CCONJ
gs-1140	116	8	atopy	atopy	NOUN
gs-1140	116	9	on	on	ADP
gs-1140	116	10	a	a	DET
gs-1140	116	11	susceptible	susceptible	ADJ
gs-1140	116	12	genetic	genetic	ADJ
gs-1140	116	13	background	background	NOUN
gs-1140	116	14	.	.	PUNCT
gs-1140	117	1	j	j	PROPN
gs-1140	117	2	autoimmun	autoimmun	PROPN
gs-1140	117	3	.	.	PUNCT
gs-1140	118	1	2012	2012	NUM
gs-1140	118	2	;	;	PUNCT
gs-1140	119	1	39:388–397	39:388–397	NUM
gs-1140	119	2	.	.	PUNCT
gs-1140	119	3	doi:10.1016	doi:10.1016	PROPN
gs-1140	119	4	/	/	SYM
gs-1140	119	5	j.jaut.2012.06.003	j.jaut.2012.06.003	PROPN
gs-1140	119	6	;	;	PUNCT
gs-1140	119	7	17	17	NUM
gs-1140	119	8	.	.	PUNCT
gs-1140	120	1	yukawa	yukawa	PROPN
gs-1140	120	2	k	k	PROPN
gs-1140	120	3	,	,	PUNCT
gs-1140	120	4	kishino	kishino	PROPN
gs-1140	120	5	m	m	PROPN
gs-1140	120	6	,	,	PUNCT
gs-1140	120	7	goda	goda	PROPN
gs-1140	120	8	m	m	PROPN
gs-1140	120	9	,	,	PUNCT
gs-1140	120	10	et	et	PROPN
gs-1140	120	11	al	al	PROPN
gs-1140	120	12	.	.	PUNCT
gs-1140	120	13	stat6	stat6	PROPN
gs-1140	120	14	de	de	PROPN
gs-1140	120	15	ciency	ciency	NOUN
gs-1140	120	16	inhibits	inhibit	VERB
gs-1140	120	17	tubulointerstitial	tubulointerstitial	ADJ
gs-1140	120	18	brosis	brosis	NOUN
gs-1140	120	19	in	in	ADP
gs-1140	120	20	obstructive	obstructive	ADJ
gs-1140	120	21	nephropathy	nephropathy	NOUN
gs-1140	120	22	.	.	PUNCT
gs-1140	121	1	int	int	PROPN
gs-1140	121	2	j	j	PROPN
gs-1140	121	3	mol	mol	ADP
gs-1140	121	4	med	med	PROPN
gs-1140	121	5	.	.	PUNCT
gs-1140	122	1	2005;15:225–230	2005;15:225–230	NUM
gs-1140	122	2	;	;	PUNCT
gs-1140	122	3	18	18	NUM
gs-1140	122	4	.	.	PUNCT
gs-1140	123	1	thomsen	thomsen	PROPN
gs-1140	123	2	sf	sf	PROPN
gs-1140	123	3	,	,	PUNCT
gs-1140	123	4	kyvik	kyvik	PROPN
gs-1140	123	5	ko	ko	PROPN
gs-1140	123	6	,	,	PUNCT
gs-1140	123	7	backer	backer	NOUN
gs-1140	123	8	v.	v.	ADP
gs-1140	123	9	etiological	etiological	ADJ
gs-1140	123	10	relationships	relationship	NOUN
gs-1140	123	11	in	in	ADP
gs-1140	123	12	atopy	atopy	NOUN
gs-1140	123	13	:	:	PUNCT
gs-1140	123	14	a	a	DET
gs-1140	123	15	review	review	NOUN
gs-1140	123	16	of	of	ADP
gs-1140	123	17	twin	twin	ADJ
gs-1140	123	18	studies	study	NOUN
gs-1140	123	19	.	.	PUNCT
gs-1140	124	1	twin	twin	PROPN
gs-1140	124	2	res	re	NOUN
gs-1140	124	3	hum	hum	PROPN
gs-1140	124	4	genet	genet	PROPN
gs-1140	124	5	.	.	PUNCT
gs-1140	125	1	2008	2008	NUM
gs-1140	125	2	;	;	PUNCT
gs-1140	126	1	11:1112–1120	11:1112–1120	NUM
gs-1140	126	2	.	.	PUNCT
gs-1140	126	3	doi:10.1375	doi:10.1375	ADJ
gs-1140	126	4	/	/	SYM
gs-1140	126	5	twin.11.2.112	twin.11.2.112	NUM
gs-1140	126	6	;	;	PUNCT
gs-1140	126	7	georgian	georgian	PROPN
gs-1140	126	8	scientists/	scientists/	NUM
gs-1140	126	9	.	.	PUNCT
gs-1140	127	1	4	4	NUM
gs-1140	127	2	n	n	PRON
gs-1140	127	3	3	3	NUM
gs-1140	127	4	,	,	PUNCT
gs-1140	127	5	2022	2022	NUM
gs-1140	127	6	266	266	NUM
gs-1140	127	7	19	19	NUM
gs-1140	127	8	.	.	PUNCT
gs-1140	128	1	miyazaki	miyazaki	PROPN
gs-1140	128	2	c	c	PROPN
gs-1140	128	3	,	,	PUNCT
gs-1140	128	4	koyama	koyama	PROPN
gs-1140	128	5	m	m	PROPN
gs-1140	128	6	,	,	PUNCT
gs-1140	128	7	ota	ota	PROPN
gs-1140	128	8	e	e	NOUN
gs-1140	128	9	,	,	PUNCT
gs-1140	128	10	et	et	PROPN
gs-1140	128	11	al	al	PROPN
gs-1140	128	12	.	.	PROPN
gs-1140	128	13	allergic	allergic	ADJ
gs-1140	128	14	diseases	disease	NOUN
gs-1140	128	15	in	in	ADP
gs-1140	128	16	children	child	NOUN
gs-1140	128	17	with	with	ADP
gs-1140	128	18	attention	attention	NOUN
gs-1140	128	19	de	de	X
gs-1140	128	20	cit	cit	PROPN
gs-1140	128	21	hyperactivity	hyperactivity	NOUN
gs-1140	128	22	disorder	disorder	NOUN
gs-1140	128	23	:	:	PUNCT
gs-1140	128	24	a	a	DET
gs-1140	128	25	systematic	systematic	ADJ
gs-1140	128	26	review	review	NOUN
gs-1140	128	27	and	and	CCONJ
gs-1140	128	28	meta	meta	ADJ
gs-1140	128	29	-	-	PUNCT
gs-1140	128	30	analysis	analysis	NOUN
gs-1140	128	31	.	.	PUNCT
gs-1140	129	1	bmc	bmc	ADJ
gs-1140	129	2	psychiatry	psychiatry	NOUN
gs-1140	129	3	.	.	PUNCT
gs-1140	130	1	2017	2017	NUM
gs-1140	130	2	;	;	PUNCT
gs-1140	130	3	17:120	17:120	NUM
gs-1140	130	4	.	.	PUNCT
gs-1140	131	1	doi:10.1186	doi:10.1186	NOUN
gs-1140	131	2	/	/	SYM
gs-1140	131	3	s12888	s12888	VERB
gs-1140	131	4	-	-	ADJ
gs-1140	131	5	017	017	NUM
gs-1140	131	6	-	-	PUNCT
gs-1140	131	7	1489	1489	NUM
gs-1140	131	8	-	-	SYM
gs-1140	131	9	6	6	NUM
gs-1140	131	10	.	.	PUNCT
gs-1140	132	1	(	(	PUNCT
gs-1140	132	2	)	)	PUNCT
gs-1140	132	3	.	.	PUNCT
gs-1140	133	1	1	1	NUM
gs-1140	133	2	,	,	PUNCT
gs-1140	133	3	.	.	PUNCT
gs-1140	134	1	2	2	NUM
gs-1140	134	2	,	,	PUNCT
gs-1140	134	3	.	.	PUNCT
gs-1140	135	1	2	2	NUM
gs-1140	135	2	1	1	NUM
gs-1140	135	3	2	2	NUM
gs-1140	135	4	(	(	PUNCT
gs-1140	135	5	)	)	PUNCT
gs-1140	135	6	,	,	PUNCT
gs-1140	135	7	,	,	PUNCT
gs-1140	135	8	,	,	PUNCT
gs-1140	135	9	,	,	PUNCT
gs-1140	135	10	.	.	PUNCT
gs-1140	136	1	15–20	15–20	NUM
gs-1140	136	2	%	%	NOUN
gs-1140	136	3	,	,	PUNCT
gs-1140	136	4	1	1	NUM
gs-1140	136	5	-	-	SYM
gs-1140	136	6	3	3	NUM
gs-1140	136	7	%	%	NOUN
gs-1140	136	8	.	.	PUNCT
gs-1140	137	1	,	,	PUNCT
gs-1140	137	2	,	,	PUNCT
gs-1140	137	3	.	.	PUNCT
gs-1140	137	4	.	.	PUNCT
gs-1140	138	1	.	.	PUNCT
gs-1140	139	1	315	315	NUM
gs-1140	139	2	18	18	NUM
gs-1140	139	3	69	69	NUM
gs-1140	139	4	.	.	PUNCT
gs-1140	140	1	154	154	NUM
gs-1140	140	2	161	161	NUM
gs-1140	140	3	(	(	PUNCT
gs-1140	140	4	,	,	PUNCT
gs-1140	140	5	)	)	PUNCT
gs-1140	140	6	.	.	PUNCT
gs-1140	141	1	(	(	PUNCT
gs-1140	141	2	)	)	PUNCT
gs-1140	141	3	(	(	PUNCT
gs-1140	141	4	,	,	PUNCT
gs-1140	141	5	,	,	PUNCT
gs-1140	141	6	,	,	PUNCT
gs-1140	141	7	,	,	PUNCT
gs-1140	141	8	)	)	PUNCT
gs-1140	141	9	.	.	PUNCT
gs-1140	142	1	:	:	PUNCT
gs-1140	143	1	18	18	NUM
gs-1140	143	2	-	-	SYM
gs-1140	143	3	29	29	NUM
gs-1140	143	4	;	;	PUNCT
gs-1140	143	5	30	30	NUM
gs-1140	143	6	-	-	SYM
gs-1140	143	7	49	49	NUM
gs-1140	143	8	50	50	NUM
gs-1140	143	9	-	-	SYM
gs-1140	143	10	69	69	NUM
gs-1140	143	11	.	.	PUNCT
gs-1140	144	1	25	25	NUM
gs-1140	144	2	spss	spss	PROPN
gs-1140	144	3	review	review	NOUN
gs-1140	144	4	manager	manager	NOUN
gs-1140	144	5	5.4.1	5.4.1	NUM
gs-1140	144	6	.	.	PUNCT
gs-1140	144	7	(	(	PUNCT
gs-1140	144	8	or	or	CCONJ
gs-1140	144	9	)	)	PUNCT
gs-1140	144	10	95	95	NUM
gs-1140	144	11	%	%	NOUN
gs-1140	144	12	,	,	PUNCT
gs-1140	144	13	p	p	NOUN
gs-1140	144	14	0.05	0.05	NUM
gs-1140	144	15	.	.	PUNCT
gs-1140	144	16	4	4	NUM
gs-1140	144	17	.	.	PUNCT
gs-1140	144	18	,	,	PUNCT
gs-1140	144	19	,	,	PUNCT
gs-1140	144	20	30	30	NUM
gs-1140	144	21	-	-	SYM
gs-1140	144	22	69	69	NUM
gs-1140	144	23	.	.	PUNCT
gs-1140	145	1	,	,	PUNCT
gs-1140	145	2	,	,	PUNCT
gs-1140	145	3	,	,	PUNCT
gs-1140	145	4	,	,	PUNCT
gs-1140	145	5	,	,	PUNCT
gs-1140	145	6	.	.	PUNCT
gs-1140	146	1	,	,	PUNCT
gs-1140	146	2	georgian	georgian	NOUN
gs-1140	146	3	scientists/	scientists/	NUM
gs-1140	146	4	.	.	PUNCT
gs-1140	147	1	4	4	NUM
gs-1140	147	2	n	n	PRON
gs-1140	147	3	3	3	NUM
gs-1140	147	4	,	,	PUNCT
gs-1140	147	5	2022	2022	NUM
gs-1140	147	6	267	267	NUM
gs-1140	147	7	,	,	PUNCT
gs-1140	147	8	;	;	PUNCT
gs-1140	147	9	.	.	PUNCT
gs-1140	148	1	,	,	PUNCT
gs-1140	148	2	.	.	PUNCT
gs-1140	149	1	(	(	PUNCT
gs-1140	149	2	ad	ad	NOUN
gs-1140	149	3	)	)	PUNCT
gs-1140	149	4	.	.	PUNCT
gs-1140	150	1	1	1	NUM
gs-1140	150	2	,	,	PUNCT
gs-1140	150	3	.	.	PUNCT
gs-1140	151	1	2	2	NUM
gs-1140	151	2	,	,	PUNCT
gs-1140	151	3	.	.	PUNCT
gs-1140	152	1	2	2	NUM
gs-1140	152	2	1	1	NUM
gs-1140	152	3	2	2	NUM
gs-1140	152	4	(	(	PUNCT
gs-1140	152	5	ad	ad	NOUN
gs-1140	152	6	)	)	PUNCT
gs-1140	152	7	,	,	PUNCT
gs-1140	152	8	,	,	PUNCT
gs-1140	152	9	.	.	PUNCT
gs-1140	152	10	.	.	PUNCT
gs-1140	152	11	.	.	PUNCT
gs-1140	153	1	(	(	PUNCT
gs-1140	153	2	)	)	PUNCT
gs-1140	153	3	.	.	PUNCT
gs-1140	154	1	18	18	NUM
gs-1140	154	2	69	69	NUM
gs-1140	154	3	315	315	NUM
gs-1140	154	4	.	.	PUNCT
gs-1140	155	1	154	154	NUM
gs-1140	155	2	161	161	NUM
gs-1140	155	3	.	.	PUNCT
gs-1140	156	1	(	(	PUNCT
gs-1140	156	2	,	,	PUNCT
gs-1140	156	3	,	,	PUNCT
gs-1140	156	4	,	,	PUNCT
gs-1140	156	5	,	,	PUNCT
gs-1140	156	6	)	)	PUNCT
gs-1140	156	7	.	.	PUNCT
gs-1140	157	1	25	25	NUM
gs-1140	157	2	spss	spss	PROPN
gs-1140	157	3	review	review	NOUN
gs-1140	157	4	manager	manager	NOUN
gs-1140	157	5	5.4.1	5.4.1	X
gs-1140	157	6	.	.	PUNCT
gs-1140	158	1	(	(	PUNCT
gs-1140	158	2	ors	or	NOUN
gs-1140	158	3	)	)	PUNCT
gs-1140	158	4	95	95	NUM
gs-1140	158	5	%	%	NOUN
gs-1140	158	6	,	,	PUNCT
gs-1140	158	7	0.05	0.05	NUM
gs-1140	158	8	.	.	NOUN
gs-1140	158	9	4	4	NUM
gs-1140	158	10	.	.	PUNCT
gs-1140	159	1	,	,	PUNCT
gs-1140	159	2	(	(	PUNCT
gs-1140	159	3	30	30	NUM
gs-1140	159	4	-	-	SYM
gs-1140	159	5	69	69	NUM
gs-1140	159	6	)	)	PUNCT
gs-1140	159	7	,	,	PUNCT
gs-1140	159	8	,	,	PUNCT
gs-1140	159	9	.	.	PUNCT
gs-1140	160	1	,	,	PUNCT
gs-1140	160	2	,	,	PUNCT
gs-1140	160	3	,	,	PUNCT
gs-1140	160	4	.	.	PUNCT
gs-1140	161	1	,	,	PUNCT
gs-1140	161	2	.	.	PUNCT